Generic Medicine Drugs

S. NO.	NAME OF PRODUCT	COMPOSITION	OFFICIAL PHARMACOPOEIA	DCGI DATE	PP DATE
1	ACECLOFENAC TABLETS IP	EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, April 05, 2007
2	CIPROFLOXACIN HYDROCHLORIDE TABLETS IP 500 MG	EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, May 01, 1989
3	DICYCLOMINE HYDROCHLORIDE & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS DICYCLOMINE HYDROCHLORIDE IP 20 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S.
4	ETODOLAC 400 MG & PARACETAMOL 325 MG TABLETS	EACH FILM COATED TABLET CONTAINS ETODOLAC IP 400 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
5	PARACETAMOL TABLETS IP 500 MG	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG EXCIPIENTS Q.S.	IP
6	DROTAVERINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS DROTAVERINE HYDROCHLORIDE IP 80 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
7	DICLOFENAC SODIUM & PARACETAMOL TABLETS IP	EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S.	IP	Wednesday, January 30, 2008
8	DICLOFENAC GEL IP	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W BENZYL ALCOHOL IP 1.00%W/W (AS PRESERVATIVE) GEL BASE Q.S.	IP	Friday, March 01, 1991
9	ISOTRETINOIN CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS ISOTRETINOIN IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS	IP	Friday, June 21, 2002
10	URSODEOXYCHOLIC ACID TABLETS IP 300 MG	EACH FILM COATED TABLET CONATINS URSODEOXYCHOLIC ACID IP 300 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, April 12, 2001
11	DICLOFENAC DIETHYLAMINE, MENTHOL & METHYL SALICYLATE GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W GEL BASE Q.S.		Sunday, August 17, 2014
12	ESCITALOPRAM OXALATE TABLETS IP	EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, December 12, 2007
13	ITRACONAZOLE GEL 1% W/W	COMPOSITION ITRACONAZOLE BP 1.00% W/W METHYL PARABEN IP 0.10% W/W PROPYL PARABEN IP 0.05% W/W IN A GEL BASE Q.S.
14	LOSARTAN POTASSIUM TABLETS IP 25 MG	EACH FILM COATED TABLET CONTAINS LOSARTAN POTTASIUM IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 16, 1998
15	ESCITALOPRAM OXALATE TABLETS IP	EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, January 24, 2003
16	LEVETIRACETAM TABLETS BP	EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 750 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, April 05, 2005
17	ESOMEPRAZOLE GASTRO- RESISTANT TABLETS IP 40 MG	EACH ENTERIC COATED TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ TO ESOMEPRAZOLE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, December 04, 2001
18	IVERMECTIN & ALBENDAZOLE TABLETS	EACH UNCOATED CHEWABLE TABLET CONTAINS IVERMECTIN IP 12 MG ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Saturday, April 25, 2009
19	IVERMECTIN & ALBENDAZOLE TABLETS	EACH UNCOATED CHEWABLE TABLET CONTAINS IVERMECTIN IP 6 MG ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Saturday, April 25, 2009
20	OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM IP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
21	ALBENDAZOLE AND IVERMECTIN SUSPENSION	EACH 5 ML CONTAINS ALBENDAZOLE IP 200 MG IVERMECTIN IP 1.5 MG FLAVOURED SYRUP BASE APPROVED COLOUR USED
22	ACICLOVIR DISPERSIBLE TABLETS IP 800 MG	EACH DISPERSIBLE UNCOATED TABLET CONTAINS ACICLOVIR IP 800 MG EXCIPIENTS Q.S.	IP
23	LEVOCETIRIZINE DIHYDROCHLORIDE & MONTELUKAST TABLETS IP	EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG LEVOCETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, January 31, 2008
24	CIPROFLOXACIN HYDROCHLORIDE & ORNIDAZOLE TABLETS	EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, February 03, 2003
25	ALBENDAZOLE SUSPENSION IP	EACH 5 ML CONTAINS ALBENDAZOLE IP 200 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED	IP	Saturday, February 01, 1986
26	PROPRANOLOL HYDROCHLORIDE (SR) & FLUNARIZINE DIHYDROCHLORIDE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS SUSTAINED RELEASE) FLUNARIZINE DIHYDROCHLORIDE BP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATN CAPSULE SHELL		Tuesday, March 16, 2010
27	ALBENDAZOLE CHEWABLE TABLETS IP 400 MG	EACH UNCOATED CHEWABLE TABLET CONTAINS ALBENDAZOLE IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Saturday, February 01, 1986
28	AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE & MENTHOL SYRUP	EACH 10 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 30 MG GUAIPHENESIN IP 100 MG TERBUTALINE SULPHATE IP 2.5 MG MENTHOL IP 5 MG FLAVOURED SYRUPY BASE. Q.S. APPROVED COLOUR USED
29	KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS	EACH UNCOATED DISPERSIBLE TABLET CONTAINS KETOROLAC TROMETHAMINE IP 10 MG EXCIPIENTS Q.S.		Wednesday, April 29, 2015
30	NORTRIPTYLINE TABLETS IP	EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
31	ACICLOVIR DISPERSIBLE TABLETS IP 400 MG	EACH DISPERSIBLE UNCOATED TABLET CONTAINS ACICLOVIR IP 400 MG EXCIPIENTS Q.S.	IP
32	CIPROFLOXACIN HYDROCHLORIDE TABLETS IP 250 MG	EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, May 01, 1989
33	DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE & BENZYL ALCOHOL GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16 % W/W EQ TO DICLOFENAC SODIUM 1.0 % W/W OLEUM LINI BP 3.0 % W/W (CONT. PREDOMINANTLY a-LINOLENIC ACID) METHYL SALICYLATE IP 10.0 % W/W MENTHOL IP 5.0 % W/W BENZYL ALCOHOL IP 1.0 % W/W (AS PERSERVATIVE) GEL BASE Q.S.
34	PROPRANOLOL HYDROCHLORIDE SUSTIANED RELEASE TABLETS	EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
35	CIPROFLOXACIN AND TINIDAZOLE TABLETS	EACH FILM COATED TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDE IP EQ TO CIPROFLOXACIN 500 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
36	SILDENAFIL CITRATE TABLETS IP 100 MG	EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, January 08, 2001
37	AMBROXOL HYDROCHLORIDE & CETIRIZINE HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS AMBROXOL HYDROCHLORIDE IP 60 MG CETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
38	LEVOCETIRIZINE HYDROCHLORIDE & PHENYLEPHRINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
39	PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS	EACH SUSTAINED RELEASE UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
40	FLUOXETINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ TO FLUOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
41	PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE) & FLUNARIZINE DIHYDROCHLORIDE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS SUSTAINED RELEASE) FLUNARIZINE DIHYDROCHLORIDE BP EQ TO FLUNARIZINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS		Saturday, March 13, 2010
42	PROPRANOLOL HYDROCHLORIDE TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 10 MG EXCIPIENTS Q. S APPROVED COLOUR USED	IP	1971-November
43	PROPRANOLOL HYDROCHLORIDE (EXTENDED RELEASE) & FLUNARIZINE DIHYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 40 MG (AS EXTENDED RELEASE) FLUNARIZINE DIHYDROCHLORIDE IP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Saturday, March 13, 2010
44	FLUOXETINE HYDROCHLORIDE CAPSULES IP 20 MG	EACH HARD GELATIN CAPSULE CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 20 MG EXCIPIENT Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS	IP	1990-March
45	ORNIDAZOLE & POVIDONE IODINE OINTMENT	COMPOSITION POVIDONE IODINE IP 5.0 % W/W (0.5%W/W AVAILABLE IODINE) ORNIDAZOLE IP 1.0 % W/W WATER SOLUBLE OINTMENT BASE Q.S.		Tuesday, January 03, 2012
46	FLUOXETINE HYDROCHLORIDE CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 1.0 MG EXCIPIENT Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS	IP
47	FLUOXETINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ TO FLUOXETINE 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS	IP
48	PROPRANOLOL HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 0.5 MG EXCIPIENTS Q. S APPROVED COLOUR USED	IP
49	POVIDONE IODINE OINTMENT BP	COMPOSITION POVIDONE IODINE IP 5% W/W (0.5%W/W AVAILABLE IODINE) OINTMENT BASE Q.S.	USP	Wednesday, November 01, 1972
50	SUCRALFATE & POVIDONE IODINE OINTMENT	COMPOSITION POVIDONE IODINE IP 5.00% W/W (AVAILABLE IODINE 0.50% W/W SUCRALFATE IP 7.0% W/W WATER SOLUBLE OINTMENT BASE Q.S.		Tuesday, August 23, 2005
51	POVIDONE IODINE OINTMENT BP	COMPOSITION POVIDONE IODINE IP 10.0 % W/W (1.0 %W/W AVAILABLE IODINE) WATER WASHABLE BASE Q.S.	USP	Wednesday, November 01, 1972
52	FLUOXETINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
53	AMBROXOL HYDROCHLORIDE, GUAIPHENESIN & PHENYLEPHRINE HYDROCHLORIDE SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG PHENYLEPHRINE HYDROCHLORIDE IP 2.5 MG IN A FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
54	AMLODIPINE & ATENOLOL TABLETS IP	EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, May 20, 1996
55	AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE & MENTHOL SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG TERBUTALINE SULPHATE IP 2.5 MG MENTHOL IP 2.5 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
56	TOPIRAMATE TABLETS IP 25 MG	EACH FILM COATED TABLET CONTAINS TOPIRAMATE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, August 23, 1999
57	OFLOXACIN & TINIDAZOLE TABLETS	EACH FILM COATED TABLET CONTAINS OFLOXACIN IP 200 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
58	TRANEXAMIC ACID & ETAMSYLATE TABLETS	EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 250 MG ETAMSYLATE BP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, December 29, 2004
59	CINNARIZINE & DOMPERIDONE TABLETS	EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 20 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Saturday, February 01, 1992
60	AMLODIPINE & ATENOLOL TABLETS IP	EACH FILM COATED TABLET CONTAINS S-AMLODIPINE BESYLATE IP EQ TO S-AMLODIPINE 2.5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S.	IP	Thursday, October 17, 2002
61	OLANZAPINE MOUTH DISSOLVING TABLETS	EACH MOUTH DISSOLVING UNCOATED TABLET CONTAINS OLANZAPINE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, January 27, 2000
62	ETORICOXIB TABLETS IP	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, March 01, 2004
63	LEVOFLOXACIN TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQ TO LEVOFLOXACIN 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, July 23, 1999
64	CINNARIZINE TABLETS IP	EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, August 01, 1985
65	CINNARIZINE & DOMPERIDONE TABLETS	EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 75 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
66	ETORICOXIB TABLETS IP	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, March 01, 2004
67	NORTRIPTYLINE TABLETS IP	EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
68	BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE & NEOMYCIN CREAM	COMPOSITION BECLOMETHASONE DIPROPIONATE IP 0.05 % W/W CLOTRIMAZOLE IP 1.00 % W/W NEOMYCIN SULPHATE IP EQ. TO NEOMYCIN BASE 0.50 % W/W CREAM BASE Q.S.
69	AMLODIPINE TABLETS IP	EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, December 08, 2005
70	OLANZAPINE MOUTH DISSOLVING TABLETS	EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Saturday, May 17, 2014
71	AMLODIPINE & TELMISARTAN TABLETS IP	EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG EXCIPIENTS Q.S.		Wednesday, August 30, 2006
72	CINNARIZINE TABLETS IP	EACH UNCOATED TABLET CONTAINS CINNARIZINE IP 75 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, September 02, 2004
73	IVERMECTIN TABLET IP	EACH UNCOATED TABLET CONTAINS IVERMECTIN IP 12 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	U.S.P
74	AMLODIPINE TABLETS IP	EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, May 19, 1993
75	AMISULPRIDE TABLETS IP 50 MG	EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 50 MG EXCIPIENTS Q.S.	IP	Friday, March 12, 2010
76	OLANZAPINE MOUTH DISSOLVING TABLETS	EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, January 27, 2000
77	TRIHEXYPHENIDYL HYDROCHLORIDE & TRIFLUOPERAZINE TABLETS	EACH FILM COATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG TRIFLUOPERAZINE HYDROCHLORIDE IP EQ. TO TRIFLUOPERAZINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
78	LINEZOLID TABLETS IP 600 MG	EACH FILM COATED TABLET CONTAINS LINEZOLID IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Sunday, May 30, 2004
79	SERTACONAZOLE NITRATE CREAM 2% W/W	COMPOSITION SERTACONAZOLE NITRATE IP 2.0 % W/W PRESERVATIVE BENZYL ALCOHOL IP 1.0% W/W CREAM BASE Q.S.		Thursday, January 31, 2008
80	ETORICOXIB & THIOCOLCHICOSIDE TABLETS	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, November 17, 2008
81	LINEZOLID ORAL SUSPENSION	EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS LINEZOLID IP 100 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED		Thursday, October 04, 2001
82	TRIHEXYPHENIDYL HYDROCHLORIDE & RISPERIDONE TABLETS	EACH UNCOATED TABLET CONTAINS RISPERIDONE IP 2 MG TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
83	LINEZOLID TABLETS	EACH UNCOATED DISPERSIBLE TABLET CONTAINS LINEZOLID IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, October 04, 2001
84	IVERMECTIN CREAM	COMPOSITION IVERMECTIN IP 1.00%W/W CREAM BASE Q.S.		Wednesday, June 01, 1988
85	IVERMECTIN TABLET IP	EACH UNCOATED TABLET CONTAINS IVERMECTIN IP 6 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	2004-June
86	TELMISARTAN & HYDROCHLORTHIAZIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 80 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, August 29, 2003
87	IVERMECTIN SHAMPOO	COMPOSITION IVERMECTIN IP 0.50%W/V AQUEOUS BASE Q.S. APPROVED COLOUR USED		Wednesday, June 01, 1988
88	TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
89	TELMISARTAN & CHLORTHALIDONE TABLETS	EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
90	RISPERIDONE &TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS RISPERIDONE IP 3 MG TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, March 05, 2014
91	TELMISARTAN TABLETS IP	EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, November 25, 2002
92	TELMISARTAN & HYDROCHLORTHIAZIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, August 29, 2003
93	FLUVOXAMINE MALEATE SUSTIANED RELEASE TABLETS	EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS FLUVOXAMINE MALEATE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, August 19, 2009
94	AMISULPRIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, March 12, 2010
95	CYPROHEPTADINE HYDROCHLORIDE SYRUP IP	EACH 5 ML CONTAINS CYPROHEPTADINE HYDROCHLORIDE IP 2 MG (ANHYDROUS) FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED	IP
96	SUCRALFATE, METRONIDAZOLE & LIGNOCAINE HYDROCHORIDE CREAM	COMPOSITION SUCRALFATE IP 7.0%W/W METRONIDAZOLE IP 1.00%W/W LIGNOCAINE HYDROCHLORIDE IP 4.0%W/W CREAM BASE Q.S.		Monday, August 23, 2004
97	SUCRALFATE, METRONIDAZOLE & POVIDONE IODINE OINTMENT	COMPOSITION SUCRALFATE BP 7.0%W/W METRONIDAZOLE IP 1.00%W/W POVIDONE IODINE IP 5.0%W/W (AVIALABLE IODINE 0.50%W/W) IN OINTMENT BASE Q.S.
98	ARTEMETHER & LUMEFENTRINE TABLETS IP	EACH UNCOATED TABLET CONTAINS ARTEMETHER IP 80 MG LUMEFANTRINE IP 480 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 24, 2008
99	ARTEMETHER & LUMEFENTRINE TABLETS IP	EACH UNCOATED DISPERSIBLE TABLET CONTAINS ARTEMETHER IP 40 MG LUMEFANTRINE IP 240 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 24, 2008
100	ISOXSUPRINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S.	IP
101	AMOROLFINE HYDROCHLORIDE CREAM	COMPOSITION AMOROLFINE HYDROCHLORIDE IP EQ. TO AMOROLFINE 0.25%W/W CREAM BASE Q.S.		Tuesday, November 25, 2003
102	AMITRIPTYLINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
103	AMITRIPTYLINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
104	ISOXSUPRINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S.	IP
105	FLUVOXAMINE MALEATE TABLETS IP	EACH FILM COATED TABLET CONTAINS FLUVOXAMINE MALEATE IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, February 21, 2000
106	SILYMARIN TABLETS	EACH FILM COATED TABLET CONTAINS SILYMARIN 70 MG (AS SILYBIN) EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, June 22, 1995
107	CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE DROPS	EACH ML CONTAINS CYPROHEPTADINE HCL IP 1.5 MG (ANHYDROUS) TRICHOLINE CITRATE (65%) IP 55 MG FLAVOURED NON SYRUP BASE Q.S. APPROVED COLOUR USED
108	HALOBETASOLE PROPIONATE & SALICYLIC ACID OINTMENT	COMPOSITION HALOBETASOLE PROPIONATE USP 0.05% W/W SALICYLIC ACID IP 6.0% W/W OINTMENT BASE Q.S.
109	CLINDAMYCIN PHOSPHATE GEL BP	COMPOSITION CLINDAMYCIN PHOSPHATE IP EQ. TO CLINDAMYCIN 1% W/W PRESERVATIVE SODIUM METHYL PARABEN IP 0.114% W/W SODIUM PROPYL PARABEN IP 0.056% W/W GEL BASE Q.S.	BP	Thursday, January 19, 2012
110	CLOBAZAM TABLETS IP	EACH UNCOATED TABLET CONTAINS CLOBAZAM IP 10 MG EXCIPIENTS Q.S.	IP	Tuesday, November 11, 1997
111	ISOXSUPRINE SUSTAINED RELEASE TABLETS	EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 40 MG EXCIPIENTS Q.S.		1979-May
112	SILYMARIN TABLETS	EACH FILM COATED TABLET CONTAINS SILYMARIN 140 MG (AS SILYBIN) EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, June 22, 1995
113	ISOXSUPRINE HYDROCHLORIDE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ISOXSUPRINE HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN HARD GELATIN CAPSULES SHELL
114	CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE & BENZALKONIUM CHLORIDE GEL GEL	COMPOSITION CHOLINE SALICYLATE SOLUTION BP EQ.TO CHOLINE SALICYLATE 8.70% W/W LIGNOCAINE HYDROCHLORIDE IP 2.00% W/W BENZALKONIUM CHLORIDE SOLUTION IP 0.01% W/W (AS PRESERVATIVE) IN PLEASANT FLAVOURED GEL BASE Q.S.
115	MEFENAMIC ACID & DICYCLOMINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS MEFENAMIC ACID IP 250 MG DICYCLOMINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
116	GAMMABENZENE HEXACHLORIDE & CETRIMIDE LOTION	COMPOSITION GAMMABENZENE HEXACHLORIDE IP 1.0% W/V CETRIMIDE IP 0.1% W/V IN EMULSION BASE Q.S.
117	SILYMARIN SUSPENSION	EACH 5 ML CONTAINS SILYMARIN (AS SILYBIN) 35 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
118	CYPROHEPTADINE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS CYPROHEPTADINE HYDROCHLORIDE IP EQ, TO CYPROHEPTADINE(ANHYDROUS) 4 MG EXCIPIENTS Q.S.	IP	1973-January
119	CHLORDIAZEPOXIDE TABLET IP	EACH FILM COATED TABLET CONTAINS CHLORDIAZEPOXIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
120	WHITE SOFT PARAFFIN & LIGHT LIQUID PARAFFIN CREAM	COMPOSITION WHITE SOFT PARAFFIN IP 13.2% W/W LIGHT LIQUID PARAFFIN IP 10.2% W/W CREAM BASE Q.S.		Saturday, April 26, 2014
121	TRICHOLINE CITRATE & SORBITOL SOLUTION	EACH 5 ML CONTAINS TRICHOLINE CITRATE (65%) 275 MG SORBITOL SOLUTION (70%) IP 3.5 GM FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
122	HALOBETASOLE PROPIONATE & SALICYLIC ACID OINTMENT	COMPOSITION HALOBETASOLE PROPIONATE BP 0.05% W/W SALICYLIC ACID IP 2.0% W/W OINTMENT BASE Q.S.
123	PRIMAQUINE PHOSPHATE DISPERSIBLE TABLETS IP	EACH UNCOATED DISPERSIBLE TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 2.5 MG EXCIPIENTS Q.S.	IP
124	SALICYLIC ACID OINTMENT IP	COMPOSITION SALICYLIC ACID IP 12.0% W/W OINTMENT BASE Q.S.	IP
125	DI-SODIUM HYDROGEN CITRATE SYRUP	EACH 5 ML CONTAINS DI-SODIUM HYDROGEN CITRATE BP 1.38 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
126	CLINDAMYCIN & NICOTINAMIDE GEL	COMPOSITION CLINDAMYCIN PHOSPHATE IP EQ. TO CLINDAMYCIN 1.0% W/W NICOTINAMIDE IP 4.0% W/W IN ALOE, ALLANTION BASE WITH ETHYL LACTATE GEL BASE Q.S.		Thursday, January 19, 2012
127	PAROXETINE HYDROCHLORIDE PROLONGED RELEASE TABLETS IP	EACH FILM COATED PROLONGED RELEASE TABLET CONTAINS PAROXETINE HYDROCHLORIDE IP EQ TO PAROXETINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
128	CALAMINE & ZINC OXIDE SKIN LOTION IP	COMPOSITION CALAMINE IP 15 % W/V ZINC OXIDE IP 5 % W/V AQUEOUS BASE Q.S.	IP
129	SERTRALINE HYDROCHLORIDE TABLETS IP 100 Mg	EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, February 23, 2004
130	RISPERIDONE ORALLY DISINTEGRATING TABLETS IP	EACH ORALLY DISINTEGRATING TABLET CONTAINS RISPERIDONE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
131	PAROXETINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS PAROXETINE HYDROCHLORIDE HEMIHYDRATE IP EQ TO PAROXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, October 04, 2000
132	LEVETIRACETAM TABLETS IP 500 MG	EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, April 05, 2005
133	RISPERIDONE MOUTH DISSOLVING TABLETS	EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS RISPERIDONE IP 1.0 MG EXCIPIENTS Q.S.
134	DESVENLAFAXINE GASTRO-RESISTANT TABLETS	EACH FILM COATED GASTRO-RESISTANT TABLET CONTAINS DESVENLAFAXINE SUCCINATE EQ. TO DESVENLAFAXINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, July 20, 2009
135	CHLORDIAZEPOXIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS CHLORDIAZEPOXIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
136	DIVALPROEX SODIUM GASTRO-RESISTANT TABLETS IP 250 MG	EACH ENTERIC-COATED GASTRO-RESISTANT TABLET CONTAINS DIVALPROEX SODIUM IP EQ TO VALPROIC ACID 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, January 17, 2002
137	PRIMAQUINE PHOSPHATE TABLETS IP	EACH FILM COATED TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 7.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
138	DIVALPROEX SODIUM GASTRO-RESISTANT TABLETS IP 500 MG	EACH ENTERIC-COATED GASTRO-RESISTANT TABLET CONTAINS. DIVALPROEX SODIUM IP EQ TO VALPROIC ACID 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, January 17, 2002
139	PRIMAQUINE PHOSPHATE TABLETS IP	EACH FILM COATED TABLET CONTAINS PRIMAQUINE PHOSPHATE IP EQ TO PRIMAQUINE 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
140	SODIUM VALPROATE & VALPROIC ACID CONTROLLED RELEASE TABLETS	EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS SODIUM VALPROATE IP 200 MG VALPROIC ACID IP 87 MG (BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE 300 MG) EXCIPIENTS Q.S. APPROVED COLOUR USED
141	PAROXETINE HYDROCHLORIDE PROLONGED-RELEASE TABLETS IP 12.5 MG	EACH FILM COATED PROLONGED-RELEASE TABLET CONTAINS PAROXETINE HYDROCHLORIDE IP EQ TO PAROXETINE 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
142	SODIUM VALPROATE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS SODIUM VALPROATE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
143	ARIPIPRAZOLE TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, June 11, 2003
144	POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE TRICLOSAN TOOTH PASTE	COMPOSITION POTASSIUM NITRATE BP 5.0% W/W SODIUM MONOFLUOROPHOSPHATE USP 0.7% W/W TRICLOSAN USP 0.3% W/W IN A PLEASANTLY FLAVOURED BASE Q.S. (AVAILABLE FLUORIDE CONTENT 917 PPM WHEN PACKED) APPROVED COLOUR USED
145	FLUNARIZINE TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS FLUNARIZINE DIHYDROCHLORIDE IP EQ TO FLUNARIZINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	1990-November
146	SERTRALINE HYDROCHLORIDE TABLETS IP 50 MG	EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 09, 1998
147	MIRTAZAPINE TABLETS IP 7.5 MG	EACH FILM COATED TABLET CONTAINS MIRTAZAPINE IP 7.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
148	PROPRANOLOL HYDROCHLORIDE TABLETS IP 20 MG	EACH UNCOATED TABLET CONTAINS PROPRANOLOL HYDROCHLORIDE IP 20 MG EXCIPIENTS Q.S.	IP
149	SERTRALINE HYDROCHLORIDE TABLETS IP 25 MG	EACH FILM COATED TABLET CONTAINS SERTRALINE HYDROCHLORIDE IP EQ TO SERTRALINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 09, 1998
150	CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS	COMPOSITION CHLORBUTOL IP 5.00% W/W BENZOCAINE IP 2.50% W/W PARADICHLOROBENZENE 2.00% W/W NON AQUEOUS BASE Q.S.
151	FLUNARIZINE TABLETS IP 5 MG	EACH UNCOATED TABLET CONTAINS FLUNARIZINE DIHYDROCHLORIDE IP EQ.TO FLUNARIZINE 5 MG EXCIPIENTS Q.S.	IP	1990-November
152	ARIPIPRAZOLE TABLETS IP 15 MG	EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, June 11, 2003
153	DESVENLAFAXINE SUCCINATE EXTENDED RELEASE TABLETS 50 MG	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS DESVENLAFAXINE SUCCINATE EQ TO DESVENLAFAXINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, July 20, 2009
154	QUETIAPINE TABLET IP 50 MG	EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, June 03, 2002
155	SALBUTAMOL & THEOPHYLLINE TABLETS	EACH UNCOATED TABLET CONTAINS THEOPHYLLINE (ANHYDROUS) IP 100 MG SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 4 MG EXCIPIENTS Q.S.
156	QUETIAPINE TABLETS IP 200 MG	EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, June 03, 2002
157	PERMETHRIN LOTION	COMPOSITION PERMETHRIN 5 % W/V LOTION BASE Q.S.		Monday, March 06, 1995
158	OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION IP 0.05%W/V	COMPOSITION OXYMETAZOLINE HYDROCHLORIDE IP 0.05% W/V PRESERVATIVE BENZALKONIUM CHLORIDE SOLUTION IP 0.01% W/V IN A BUFFERED AQUEOUS SOLUTION Q.S.	IP	Wednesday, August 19, 2009
159	ARIPIRAZOLE TABLETS IP 5 MG	EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, February 23, 2004
160	DULOXETINE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS DULOXETINE HYDROCHLORIDE IP EQ TO DULOXETINE 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, November 02, 2004
161	DIETHYLCARBAMAZINE CITRATE & CHLORPHENIRAMINE MALEATE TABLETS	EACH FILM COATED TABLET CONTAINS DIETHYLCARBAMAZINE CITRATE IP 150 MG CHLORPHENIRAMINE MALEATE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
162	ARIPIPRAZOLE TABLETS IP	EACH UNCOATED TABLET CONTAINS ARIPIPRAZOLE IP 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, June 11, 2003
163	LOSARTAN POTASSIUM & HYDROCHLORTHIAZIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS LOSARTAN POTASSIUM IP 25 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, May 31, 2013
164	DOXEPIN HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS DOXEPIN HYDROCHLORIDE IP EQ TO DOXEPIN 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		1972-September
165	QUETIAPINE TABLET IP 100 MG	EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, June 03, 2002
166	LAMOTRIGINE DISPERSIBLE TABLETS IP 50 MG	EACH UNCOATED DISPERSIBLE TABLET CONTAINS LAMOTRIGINE IP 50 MG (IN A FLAVORED BASE) EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Thursday, January 20, 2000
167	IMIPRAMINE HYDROCHLORIDE TABLET IP	EACH FILM COATED TABLET CONTAINS IMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	10,25 MG
168	QUETIAPINE TABLET IP 25 MG	EACH FILM COATED TABLET CONTAINS QUETIAPINE FUMARATE IP EQ TO QUETIAPINE 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, June 03, 2002
169	DOMPERIDONE SUSPENSION IP	EACH ML CONTAINS DOMPERIDONE IP 1 MG IN FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED	IP	1978-November
170	MICONAZOLE NITRATE & FLUOCINOLONE ACETONIDE CREAM	COMPOSITION FLUOCINOLONE ACETONIDE IP 0.01% W/W MICONAZOLE NITRATE IP 2.0% W/W CREAM BASE Q.S.
171	DULOXETINE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS DULOXETINE HYDROCHLORIDE IP EQ. TO DULOXETINE 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, November 02, 2004
172	CLOMIPRAMINE HYDROCHLORIDE TABLETS 25 MG	EACH FILM COATED TABLET CONTAINS CLOMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		1992-Fabruary
173	HALOPERIDOL DISPERSIBLE TABLET IP 5 MG.	EACH DISPERSIBLE UNCOATED TABLET CONTAINS HALOPERIDOL IP 5 MG EXCIPIENTS Q.S.	IP
174	DIPHENOXYLATE HYDROCHLORIDE & ATROPINE SULPHATE IP	EACH UNCOATED TABLET CONTAINS DIPHENOXYLATE HYDROCHLORIDE IP 2.5 MG ATROPINE SULPHATE IP 0.025 MG EXCIPIENTS Q.S.	IP	1969-June
175	CARISOPRODOL TABLETS IP 350 MG	EACH UNCOATED TABLET CONTAINS CARISOPRODOL IP 350 MG EXCIPIENTS Q.S.	IP	Monday, March 01, 1965
176	LEFLUNOMIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS LEFLUNOMIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, October 01, 2001
177	GLIMEPIRIDE TABLETS IP 2 MG	EACH UNCOATED TABLET CONTAINS GLIMEPIRIDE IP 2 MG EXCIPIENTS Q.S.	IP	Sunday, January 24, 1999
178	DICYCLOMINE HYDROCHLORIDE & SIMETHICONE SUSPENSION	EACH ML CONTAINS DICYCLOMINE HYDROCHLORIDE IP 10 MG SIMETHICONE IP 40 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
179	DOXEPIN HYDROCHLORIDE TABLETS 75 MG	EACH FILM COATED TABLET CONTAINS DOXEPINE HYDROCHLORIDE IP EQ TO DOXEPIN 75 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
180	HALOPERIDOL TABLET IP	EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 1.5 MG EXCIPIENTS Q.S.	IP
181	DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE & MENTHOL SYRUP	EACH 5 ML CONTAINS DIPHENHYDRAMINE HYDROCHLORIDE IP 14.08 MG AMMONIUM CHLORIDE IP 138 MG SODIUM CITRATE IP 100 MG MENTHOL IP 1.14 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
182	THYMOL, MENTHOL, ICHTHAMMOL & LIGNOCAINE HCl OINTMENT	COMPOSITION THYMOL IP 0.50%W/W MENTHOL IP 0.20%W/W ICHTHAMMOL BP 1.00%W/W LIGNOCAINE HYDROCHLORIDE IP 1.00%W/W IN OINTMENT BASE Q.S.
183	PERMETHRIN CREAM	EACH GM CREAM CONTAINS PERMETHRIN 50 MG CREAM BASE Q.S.		Monday, March 06, 1995
184	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
185	IMIPRAMINE HYDROCHLORIDE TABLET IP 25 MG	EACH FILM COATED TABLET CONTAINS IMIPRAMINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
186	DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL & METHYL SALICYLATE GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1.00% W/W LINSEED OIL BP 3.000 % W/W MENTHOL IP 0.50% W/W METHYL SALICYLATE IP 10.000% W/W GEL BASE Q.S.
187	CLOMIPRAMINE HYDROCHLORIDE TABLETS 50 MG	EACH FILM COATED TABLET CONTAINS CLOMIPRAMINE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		1992-Fabruary
188	TACROLIMUS OINTMENT	COMPOSITION TACROLIMUS IP 0.03 % W/W OINTMENT BASE Q.S.		Friday, March 07, 2003
189	LAMOTRIGINE DISPERSIBLE TABLETS IP	EACH UNCOATED DISPERSIBLE TABLET CONTAINS LAMOTRIGINE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, April 05, 2010
190	ACECLOFENAC & THIOCOLCHICOSIDE TABLETS	EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG THIOCOLCHICOSIDE IP 8 MG EXCIPIENTS Q.S. APPROVED COLOURED USED		Monday, August 03, 2009
191	TOPIRAMATE TABLETS IP	EACH FILM COATED TABLET CONTAINS TOPIRAMATE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, August 23, 1999
192	OLANZAPINE MOUTH DISSOLVING TABLETS 10 MG	EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS OLANZAPINE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, January 27, 2000
193	GAMMABENZENE HEXACHLORIDE & CETRIMIDE LOTION	COMPOSITION GAMMABENZENE HEXACHLORIDE IP 1.0 % W/V CETRIMIDE IP 0.06% W/V IN EMULSION BASE Q.S.
194	GAMMABENZENE HEXACHLORIDE LOTION	COMPOSITION GAMMA BENZENE HEXACHLORIDE IP 1.0 % W/V IN AQUEOUS BASE Q.S.
195	SPARFLOXACIN TABLETS 200 MG	EACH FILM COATED TABLET CONTAINS SPARFLOXACIN 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, November 11, 1996
196	POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE SOLUTION BP	EACH 5 ML CONTAINS POTASSIUM CITRATE MONOHYDRATE IP 1100 MG CITRIC ACID MONOHYDRATE IP 334 MG FLAVOURED BASE Q.S. APPROVED COLOUR USED	U.S.P
197	VENLAFAXINE HYDROCHLORIDE EXTEND RELEASE TABLETS	EACH UNCOATED EXTENDE RELEASE TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE BP EQ TO VENLAFAXINE 75 MG EXCIPIENTS Q.S.		Monday, September 18, 2000
198	TACROLIMUS OINTMENT	COMPOSITION TACROLIMUS IP 0.01 % W/W OINTMENT BASE Q.S.		Friday, March 07, 2003
199	LIGNOCAINE HYDROCHLORIDE GEL IP	COMPOSITION LIGNOCAINE HYDROCHLORIDE IP 2.00%W/W METHYL PARABEN IP 0.061%W/W PROPYL PARABEN IP 0.027%W/W IN A WATER SOLUBLE GEL BASE Q.S.	IP
200	LEVAMISOLE TABLET IP	EACH UNCOATED TABLET CONTAINS LEVAMISOLE HYDROCHLORIDE IP EQ TO LEVAMISOLE 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
201	PARACETAMOL & ETODOLAC TABLETS	EACH FILM COATED TABLET CONTAINS ETODOLAC IP 400 MG PARACETAMOL IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, October 01, 2010
202	ISOSORBIDE MONONITRATE TABLETS IP	EACH UNCOATED TABLET CONTAINS DILUTED ISOSORBIDE MONONITRATE IP EQ TO ISOSORBIDE 20 MG EXCIPIENTS Q.S.	IP	1985-August
203	HYDROXYZINE HYDROCHLORIDE TABLETS IP 25 MG	EACH FILM COATED TABLET CONTAINS HYDROXYZINE HYDROCHLORIDE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
204	UREA, LACTIC ACID, PROPYLENE GLYCOL & LIQUID PARAFFIN CREAM	COMPOSITION UREA IP 10.0%W/W LACTIC ACID IP 10.0%W/W PROPYLENE GLYCOL IP 10.0%W/W LIQUID PARFAFFIN IP 10.0%W/W IN ACREAML BASE Q.S.
205	MINOCYCLINE TABLETS BP	EACH UNCOATED TABLET CONTAINS MINOCYCLINE HYDROCHLORIDE BP EQ TO MINOCYCLINE 100 MG EXCIPIENTS Q.S.	BP	1988-May
206	LACTULOSE SOLUTION BP	EACH 5ML CONTAINS LACTULOSE CONCENTRATE BP EQ. TO LACTULOSE 3.335 GM FLAVOURED SYRUP BASE Q.S.	BP
207	DEXAMETHASONE TABLETS IP	EACH UNCOATED TABLET CONTAINS DEXAMETHASONE IP 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
208	IBUPROFEN & PARACETAMOL TABLETS IP	EACH FILM COATED TABLET CONTAIN IBUPROFEN IP 400 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	1984-October
209	SULFASALAZINE DELAYED RELEASE TABLETS BP 500 MG	EACH ENTERIC COATED TABLET CONTAINS SULFASALAZINE BP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	BP
210	BUDESONIDE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS BUDESONIDE IP 3 MG (AS CONTROLLED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS		Tuesday, June 17, 2008
211	BISACODYL TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS BISACODYL IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
212	HYDROXYCHLOROQUINE SULPHATE TABLETS IP	EACH FILM COATED TABLET CONTAINS HYDROXYCHLOROQUINE SULPHATE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
213	TRIOXSALEN TABLETS BP 25 MG	EACH FILM COATED TABLET CONTAINS TRIOXSALEN BP 25 MG EXCIPIENT Q.S. APPROVED COLOUR USED	BP
214	CHLORPHENIRAMINE MALEATE TABLETS IP	EACH UNCOATED TABLET CONTAINS CHLORPHENIRAMINE MALEATE IP 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
215	ETOFYLLINE, BROMHEXINE HYDROCHLORIDE & SALBUTAMOL SULPHATE TABLETS	EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ TO SALBUTAMOL 4 MG ETOPHYLLINE (ANHYDROUS) BP 200 MG BROMHEXINE HYDROCHLORIDE IP 16 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
216	LEVETIRACETAM TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, April 05, 2005
217	LEVETIRACETAM TABLES IP	EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 1000 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	2005-May
218	LOSARTAN POTASSIUM TABLETS IP	EACH FILM COATED TABLET CONTAINS LOSARTAN POTTASIUM IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, June 16, 1998
219	DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE & BENZYL ALCOHOL GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.000% W/W LINSEED OIL BP 3.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W BENZYL ALCOHOL IP 1.0 % W/W GEL BASE Q.S.
220	URSODEOXYCHOLIC ACID IP TABLETS 150 MG	EACH UNCOATED TABLET CONATINS URSODEOXYCHOLIC ACID IP 150 MG EXCIPIENTS Q.S.	IP
221	TRAZODONE HYDROCHLORIDE TABLETS BP	EACH UNCOATED TABLET CONTAINS TRAZODONE HYDROCHLORIDE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	U.S.P
222	HALOPERIDOL TABLET IP	EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
223	PRAMIPEXOLE TABLETS	EACH UNCOATED TABLET CONTAINS PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE BP 0.5 MG EXCIPIENTS Q.S.		Monday, July 25, 2005
224	DULOXETINE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONATINS DULOXETINE HYDROCHLORIDE IP EQ TO DULOXETINE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, November 02, 2004
225	DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE & BENZYL ALCOHOL GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 2.30%W/W EQ TO DICLOFENAC SODIUM 2.00%W/W LINSEED OIL BP 3.00%W/W MENTHOL IP 5.0%W/W METHYL SALICYLATE IP 10.0%W/W BENZYL ALCOHOL IP 1.0% W/W GEL BASE Q.S.
226	DEXTROMETHORPHAN TABLET 20 MG	EACH UNCOATED TABLET CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
227	DEXTROMETHORPHAN TABLET 30 MG	EACH UNCOATED TABLET CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
228	NEOMYCIN, BECLOMETHASONE , CLOTRIMAZOLE & LIGNOCAINE EAR DROPS	COMPOSITION BECLOMETHASONE DIPROPIONATE IP 0.025% W/V CLOTRIMAZOLE IP 1.0% W/V LIGNOCAINE HYDROCHLORIDE IP 2.0% W/V NEOMYCIN SULPHATE IP 0.5% W/V IN AQUES BASE SOLUTION Q.S.
229	ISOTRETINOIN CAPSULES IP 20 MG	EACH HARD GELATIN CAPSULE CONTAINS ISOTRETINOIN IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS	IP	Friday, June 21, 2002
230	OFLOXACIN TABLETS IP 200 MG	EACH FILM COATED TABLET CONTAINS OFLOXACIN IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
231	PARACETAMOL & DROTAVERINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAIN DROTAVERINE HYDROCHLORIDE IP 80 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
232	DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE & CAPSAICIN GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ TO DICLOFENAC SODIUM 1.00% W/W LINSEED OIL BP 3.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W CAPSAICIN USP 0.025%W/W GEL BASE Q.S.
233	AMLODIPINE & TELMISARTAN TABLETS IP	EACH FILM COATED TABLET CONTAINS TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
234	LINEZOLID TABLETS IP	EACH UNCOATED TABLET CONTAINS LINEZOLID IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Sunday, May 30, 2004
235	PARACETAMOL & CAFFEINE TABLETS IP	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 650 MG CAFFEINE ANHYDROUS IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
236	DICLOFENAC SODIUM SR TABLETS IP	EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS DICLOFENC SODIUM IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	1988-January
237	HYDROXYZINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS HYDROXYZINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
238	SILDENAFIL CITRATE TABLETS BP (FOR EXPORT)	EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE BP EQ.TO SILDENAFIL 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, January 08, 2001
239	ATORVASTATIN TABLETS IP 10 MG	EACH FILM COATED TABLET CONTAINS ATORVASTATIN CALCIUM IP EQ TO ATORVASTATIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, September 17, 1999
240	ROSUVASTATIN CALCIUM TABLETS IP	EACH FILM COATED TABLET. CONTAINS ROSUVASTATIN CALCIUM EQ.TO ROSUVASTATIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Saturday, November 08, 2008
241	NORFLOXACIN TABLETS IP	EACH FILM COATED TABLET CONTAINS NORFLOXACIN IP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		1987-November
242	NIMESULIDE TABLETS 100 MG	EACH UNCOATED TABLETS CONTAINS NIMESULIDE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, January 13, 1995
243	NORFLOXACIN & TINIDAZOLE TABLETS	EACH FILM COATED TABLET CONTAINS NORFLOXACIN IP 400 MG TINIDAZOLE IP 600 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Tuesday, May 09, 1995
244	TADALAFIL TABLETS IP 20 MG	EACH FILM COATED TABLET CONTAINS TADALAFIL IP 20 MG EXCIPINTS Q.S. APPROVED COLOUR USED	IP	Thursday, September 11, 2003
245	SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE & CHLORHEXIDINE GLUCONATE CREAM	COMPOSITION SILVER SULFADIAZINE IP 1.00 % W/W LIGNOCAINE HYDROCHLORIDE IP 2.00 % W/W CHLORHEXIDINE GLUCONATE SOLUTION IP EQ. TO CHLORHEXIDINE GLUCONATE 0.20 % W/W CREAM BASE Q.S.
246	DEXTROMETHORPHAN HYDROBROMIDE & CHLORPHENIRAMINE MALEATE SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 4 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
247	AMLODIPINE & LOSARTAN POTASSIUM TABLETS IP	EACH FILM COATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ TO AMLODIPINE 5 MG LOSARTAN POTASSIUM IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
248	CHLORBUTOL, BENZOCAINE & PARADICHLOROBENZENE EAR DROPS	COMPOSITION CHLORBUTOL IP 5.00% W/V BENZOCAINE IP 2.50% W/V PARADICHLOROBENZENE 2.00% W/V NON AQUEOUS BASE Q.S.
249	CETIRIZINE TABLETS BP (FOR EXPORT)	EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE BP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
250	MIRTAZAPINE TABLETS IP 15 MG	EACH FILM COATED TABLET CONTAINS MIRTAZAPINE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Tuesday, February 13, 2001
251	ATORVASTATIN TABLETS IP	EACH FILM COATED TABLET CONTAINS ATORVASTATIN CALCIUM IP EQ TO ATORVASTATIN 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, September 17, 1999
252	PARACETAMOL DROPS	EACH ML CONTAINS PARACETAMOL IP 150 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
253	BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & TERBUTALINE SULPHATE SYRUP	EACH 5 ML CONTAINS BROMHEXINE HYDROCHLORIDE IP 2.0 MG TERBUTALINE SULPHATE IP 2.5 MG GUAIPHENESIN IP 100 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
254	OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM BP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
255	OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM BP EQ TO OMEPRAZOLE 10 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
256	THYMOL, MENTHOL, ICHTHAMMOL & LIGNOCAINE HCl OINTMENT	COMPOSITION THYMOL IP 0.50%W/W MENTHOL IP 1.0%W/W ICHTHAMMOL BP 0.20%W/W LIGNOCAINE HYDROCHLORIDE IP 1.00%W/W IN OINTMENT BASE Q.S.
257	VENLAFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE IP EQ TO VENLAFAXINE 75 MG EXCIPIENTS Q.S.		Monday, September 18, 2000
258	PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL & CHLORPHENIRAMINE MALEATE DROP	EACH ML CONTAINS PHENYLEPHRINE HYDROCHLORIDE IP 2.5 MG PARACETAMOL IP 125 MG CHLORPHENIRAMINE MALEATE IP 1 MG IN A FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
259	PRAZIQUANTEL TABLETS BP	EACH UNCOATED TABLET CONTAINS PRAZIQUANTEL BP 600 MG EXCIPIENTS Q.S.	U.S.P	1985-August
260	ILAPRAZOLE & DOMPERIDONE CAPSULES	COMPOSITION EACH HARD GELATIN CAPSULE CONTAINS ILAPRAZOLE IP 10 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS		Wednesday, May 04, 2022
261	FEXOFENADINE HYDROCHLORIDE TABLETS IP 180 mg	EACH FILM COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 180 mg EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	16/09/1998
262	TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN & MENTHOL SYRUP	EACH 5 ML CONTAINS BROMHEXINE HYDROCHLORIDE IP 4 mg TERBUTALINE SULPHATE IP 2.50 mg GUAIPHENESIN IP 100 mg MENTHOL IP 0.5 mg FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
263	LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP	EACH 5 ML CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 2.5 mg FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED		Saturday, September 29, 2007
264	ACECLOFENAC SUSTAINED RELEASE AND ENTERIC COATED RABEPRAZOLE SODIUM CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ACECLOFENAC IP 200 MG (AS SUSTAINED RELEASE PELLETS ) RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS ) EXCIPIENTS Q.S. COLOUR APPROVED COLOUR USED
265	ZONISAMIDE CAPSULES USP 100 MG	COMPOSITION EACH HARD GELATIN CAPSULE CONTAINS ZONISAMIDE IP 100 MG APPROVED COLOUR USED IN CAPSULE SHELLS.		Wednesday, December 21, 2005
266	RABEPRAZOLE GASRTO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, October 04, 2004
267	ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQUIVALENT TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED		Monday, June 26, 1905
268	PANTOPRAZOLE (EC) & LEVOSULPIRIDE (SR) CAPSULES	EACH HARD GELATIN CAPSULES CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQUIVALENT TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE 75 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED
269	RABEPRAZOLE SODIUM (EC) AND LEVOSULPIRIDE (SR) CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE 75 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, August 19, 2011
270	PARACETAMOL, PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE, SODIUM CITRATE AND MENTHOL SUSPENSION	EACH 5 ML CONTAINS - PARACETAMOL IP 250 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG SODIUM CITRATE IP 60 MG MENTHOL IP 1 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
271	CYPROHEPTADINE HYDROCHLORIDE & TRICHOLINE CITRATE SYRUP	EACH 5 ML CONTAINS CYPROHEPTADINE HCL IP 2 MG TRICHOLINE CITRATE 275 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
272	TERBUTALINE SULPHATE, GUAIPHENESIN, BROMHEXINE HCl &MENTHOL SYRUP	EACH 5 ML CONTAINS TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG BROMHEXINE HCl IP 4 MG MENTHOL IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
273	LEVOSALBUTAMOL SULPHATE, AMBROXOL HCL & GUAIPHENESIN SYRUP	EACH 5 ML CONTAINS LEVOSALBUTAMOL SULPHATE IP EQUIVALENT TO LEVOSALBUTAMOL 1 MG AMBROXOL HCL IP 30 MG GUAIPHENESIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Thursday, March 19, 2009
274	PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CHLORPHENIRAMINE MALEATE TABLETS	EACH UNCOATED TABLETS CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
275	AMBROXOL HYDROCHLORIDE, DEXTROMETHORPHAN HBr, CETIRIZINE & MENTHOL SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG DEXTROMETHORPHAN HBr IP 10 MG CETIRIZINE DIHYDROCHLORIDE IP 5 MG MENTHOL IP 0.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
276	CALCIUM CITRATE, MAGNESIUM, ZINC & VITAMIN D3TABLETS	EACH FILM COATED TABLET CONTAINS - CALCIUM CITRATE USP 1000 MG MAGNESIUM HYDROXIDE IP EQUIVALENT TO ELEMENTAL MAGNESIUM 100 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTEL ZINC 4 MG VITAMIN D3 IP 200 IU EXCIPIENTS Q.S APPROVED COLOUR USED
277	DRIED ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE AND SIMETHICONE SUSPENSION	EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE GEL IP 250 MG MAGNESIUM HYDROXIDE IP 250 MG SIMETHICONE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
278	LEVOFLOXACIN & ORNIDAZOLE TABLETS	EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQUIVALENT TO LEVOFLOXACIN 250 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, July 23, 1999
279	MILK OF MAGNESIA LIQUID PARAFFIN AND SODIUM PICOSULFATE SUSPENSION	EACH 5ML CONTAINS - LIQUID PARAFFIN IP 1.25 ML MILK OF MAGNESIA IP 3.75 ML SODIUM PICOSULFATE BP 3.33 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
280	PARACETAMOL & MEFENAMIC ACID SUSPENSION	EACH 5 ML CONTAINS - PARACETAMOL IP 250 MG MEFENAMIC ACID IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
281	MEFENAMIC ACID & PARACETAMOL SUSPENSION	EACH 5ML CONTAINS - PARACETAMOL IP 125 MG MEFENAMIC ACID IP 50.0 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
282	PARACETAMOL, CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE SUSPENSION	EACH 5 ML CONTAINS PARACETAMOL IP 250 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCI IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
283	PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SUSPENSION	EACH 5 ML CONTAINS PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
284	TRANEXAMIC ACID & MEFENAMIC ACID TABLETS	EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 500 MG MEFENAMIC ACID IP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Tuesday, February 22, 2005
285	PANTOPRAZOLE & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQUIVALENT. TO PANTOPRAZOLE 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
286	AMBROXOL HYDROCHLORIDE, GUAIPHENESIN AND TERBUTALINE SULPHATE SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG GUAIPHENESIN IP 50 MG TERBUTALINE SULPHATE IP 1.25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
287	MONTELUKAST SODIUM & LEVOCETIRIZINE HCL DISPERSIBLE TABLETS	EACH UNCOATED DISPERSIBLE TABLET CONTAINS MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 4 MG LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
288	AMBROXOL HYDROCHLORIDE, LEVOSALBUTAMOL AND GUAIPHENESIN SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG LEVOSALBUTAMOL SULPHATE IP EQUIVALENT TO LEVOSALBUTAMOL 0.5 MG GUAIPHENESIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
289	DEXTROMETHORPHAN HBr, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 15 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
290	ITRACONAZOLE CAPSULES B.P	EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS
291	OMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
292	SUCRALFATE & OXETACAINE SUSPENSION	EACH 5 ML CONTAINS SUCRALFATE IP 1 G OXETACAINE BP 20 MG FLAVOURED SYRUPY BASE Q.S.
293	DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
294	PARACETAMOL, PHENYLEPHRINE HCL & CHLORPHENIRAMINE MALEATE SUSPENSION	EACH 5 ML CONTAINS PARACETAMOL IP 125 MG PHENYLEPHRINE HCL IP 2.5 MG CHLORPHENIRAMINE MALEATE IP 1 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
295	PARACETAMOL ORAL SUSPENSION IP	EACH 5 ML CONTAINS PARACETAMOL IP 250 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
296	PANTOPRAZOLE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, May 20, 2005
297	LEVOCETIRIZINE DIHYDROCHLORIDE WITH MONTELUKAST SODIUM SYRUP	EACH 5 ML CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE 2.5 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 4 MG IN A FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
298	AMBROXOL HCL, TERBUTALINE, GUAIPHENESIN AND MENTHOL SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE 15 MG TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG MENTHOL IP 2.5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED		Wednesday, March 26, 2008
299	ONDANSETRON ORAL SOLUTION IP	EACH 5 ML CONTAINS ONDANSETRON HYDROCHLORIDE IP EQUIVALENT TO ONDANSETRON 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
300	ACECLOFENAC & PARACETAMOL TABLETS 100/325 MG	EACH UNCOATED BILAYERED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
301	RABEPRAZOLE GASTRO-RESISTANT TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS RABEPRAZOLE SODIUM IP 20 MG EXCEIPIENTS Q.S. APPROVED COLOUR USED		Thursday, December 27, 2001
302	DOXYLAMINE SUCCINATE 10 MG, PYRIDOXINE HYDROCHLORIDE 10 MG & FOLIC ACID 2.5 MG TABLETS	EACH ENTERIC COATED TABLET CONTAINS DOXYLAMINE SUCCINATE BP 10 MG PYRIDOXINE HYDROCHLORIDE IP 10 MG FOLIC ACID IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
303	LACTULOSE SOLUTION USP	EACH 15 ML CONTAINS LACTULOSE SOLUTION BP EQUIVALENT TO LACTULOSE 10 GM FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED	USP	Thursday, February 08, 2007
304	FERROUS ASCORBATE & FOLIC ACID SYRUP	EACH 5 ML CONTAINS FERROUS ASCORBATE EQUIVALENT TO ELEMENTAL IRON 30 MG FOLIC ACID IP 550 MCG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
305	CALCIUM CARBONATE & VITAMIN D3 TABLETS	EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 250 IU EXCIPIENTS Q.S. APPROVED COLOUR USED
306	CALCIUM CITRATE, VITAMIN D3, MAGNESIUM & ZINC TABLETS	EACH FILM-COATED TABLET CONTAINS CALCIUM CITRATE USP 1000 MG MAGNESIUM HYDROXIDE IP EQUIVALENT TO ELEMENTAL MAGNESIUM 100 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTAL ZINC 4 MG VITAMIN D3 IP 1000 IU EXCIPIENTS Q.S. APPROVED COLOUR USED
307	CALCIUM CITRATE, CALCITRIOL & ZINC TABLETS	EACH FILM-COATED TABLET CONTAINS CALCIUM CITRATE USP 1000 MG CALCITRIOL IP 0.25 MG ZINC SULPHATE MONOHYDRATE IP EQUIVALENT TO ELEMENTAL ZINC 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
308	DEFLAZACORT TABLETS	EACH UNCOATED TABLET CONTAINS DEFLAZACORT 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
309	FEXOFENADINE HYDROCHLORIDE & MONTELUKAST TABLETS	EACH FILM-COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 180 MG MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
310	METFORMIN PROLONGED RELEASE AND GLIMEPIRIDE TABLETS IP	EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HCL IP 500 MG (IN PROLONGED-RELEASE FROM) EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, November 13, 2002
311	PIRACETAM TABLETS	EACH FILM COATED TABLET CONTAINS PIRACETAM IP 800 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
312	RABEPRAZOLE SODIUM & DOMPERIDONE TABLETS	EACH ENTERIC-COATED TABLET CONTAINS RABEPRAZOLE SODIUM IP 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
313	ITRACONAZOLE CAPSULES BP	EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS
314	OXCARBAMEZEPINE TABLETS IP 600 MG	EACH FILM -COATED TABLET CONTAINS OXCARBAMAZEPINE IP 600 MG EXCIPENTS Q.S. APPROVED COLOUR USED
315	DEFLAZACORT TABLETS	EACH UNCOATED TABLET CONTAINS DEFLAZACORT 6 MG EXCIPIENTS Q.S.
316	CLOTRIMAZOLE VAGINAL TABLETS IP	EACH UNCOATED TABLET CONTAINS CLOTRIMAZOLE IP 100 MG EXCIPIENTS Q.S.	IP	Tuesday, February 17, 1998
317	DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE, LINSEED OIL & THIOCOLCHICOSIDE GEL	COMPOSITION DICLOFENAC DIETHYLAMINE IP 1.16% W/W EQ. TO DICLOFENAC SODIUM 1.00% W/W MENTHOL IP 5.00% W/W METHYL SALICYLATE IP 10.00% W/W LINSEED OIL BP 3.00% W/W THIOCOLCHICOSIDE IP 0.125% W/W GEL BASE Q.S.
318	ITRACONAZOLE CAPSULES BP	EACH HARD GELATIN CAPSULE CONTAINS ITRACONAZOLE PELLETS EQUIVALENT TO ITRACONAZOLE BP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN THE CAPSULE SHELLS
319	METHYLDOPA TABLETS IP 500 MG	EACH FILM COATED TABLET CONTAINS METHYLDOPA IP EQUIVALENT TO ANHYDROUS METHYLDOPA 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
320	METHYLDOPA TABLETS IP 250 MG	EACH FILM COATED TABLET CONTAINS METHYLDOPA IP EQUIVALENT TO ANHYDROUS METHYLDOPA 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
321	DEFLAZACORT TABLETS	EACH UNCOATED TABLET CONTAINS DEFLAZACORT 1 MG EXCIPIENTS Q.S.
322	LOPERAMIDE CAPSULES IP 2 MG	EACH HARD GELATIN CAPSULE CONTAINS LOPERAMIDE HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS	IP
323	LOPERAMIDE HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS LOPERAMIDE HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S.	IP
324	CETIRIZINE TABLETS IP	EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
325	CALCIUM CARBONATE & VITAMIN D3 TABLETS	EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 500 IU EXCIPIENTS Q.S. APPROVED COLOUR USED
326	TADALAFIL TABLETS IP 10 MG	EACH FILM COATED TABLET CONTAINS TADALAFIL IP 10 MG EXCIPINTS Q.S. APPROVED COLOUR USED	IP	Thursday, September 11, 2003
327	TERBUTALINE SULPHATE, BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN TABLETS	EACH UNCOATED TABLET CONTAINS BROMHEXINE HYDROCHLORIDE IP 4 MG TERBUTALINE SULPHATE IP 2.5 MG GUAIPHENESIN IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
328	BROMOCRIPTINE MESYLATE TABLETS IP	EACH UNCOATED TABLET CONTAINS BROMOCRIPTINE MESYLATE IP 2.87 MG EQ. TO BROMOCRIPTINE 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	1987-July
329	TRANEXAMIC ACID TABLETS IP	EACH FILM COATED TABLET CONTAINS TRANEXAMIC ACID IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, March 06, 2002
330	DRIED ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE AND SIMETHICONE SUSPENSION	EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE GEL IP 200 MG MAGNESIUM HYDROXIDE IP 200 MG SIMETHICONE IP 25 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
331	SILDENAFIL CITRATE TABLETS IP 50 MG	EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Monday, January 08, 2001
332	PARACETAMOL TABLETS IP 650 MG	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 650 MG EXCIPIENTS Q.S.	IP
333	NIMESULIDE & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS NIMESULIDE BP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. NOT FOR USE BELOW 12 YEARS OF AGE
334	ACECLOFENAC & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
335	CETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE AND PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS CETIRIZINE HYDROCHLORIDE IP 5 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
336	ACECLOFENAC & PARACETAMOL TABLETS	EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
337	ACECLOFENAC, PARACETAMOL & CHLORZOXAZONE TABLETS	EACH UNCOATED TABLET CONTAINS ACECLOFENAC IP 100 MG PARACETAMOL IP 325 MG CHLORZOXAZONE USP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
338	DICLOFENAC POTASSIUM, PARACETAMOL AND CHLORZOXAZONE TABLETS	EACH UNCOATED TABLET CONTAINS DICLOFENAC POTASSIUM IP 50 MG PARACETAMOL IP 325 MG CHLORZOXAZONE USP 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
339	GLIMEPIRIDE AND METFORMIN HCl SUSTAINED RELEASE TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HCl IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED		Sunday, November 13, 2022
340	ONDANSETRON ORALLY DISINTEGRATING TABLETS IP	EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS ONDANSETRON HYDROCHLORIDE IP EQ. TO ONDANSETRON 4 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, October 10, 2007
341	METFORMIN HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S.	IP	Friday, November 09, 2001
342	METFORMIN HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS METFORMIN HYDROCHLORIDE IP 850 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
343	GLIMEPIRIDE AND METFORMIN HCl SUSTAINED RELEASE TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS GLIMEPIRIDE IP 1 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, November 13, 2002
344	ONDANSETRON ORALLY DISINTEGRATING TABLETS	EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS ONDANSETRON HYDROCHLORIDE IP EQ. TO ONDANSETRON 2 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
345	TENELIGLIPTIN AND METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP	EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 500 MG (PROLONGED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
346	DICLOFENAC SODIUM & PARACETAMOL TABLETS IP	EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
347	TENELIGLIPTIN 20 MG AND METFORMIN HYDROCHLORIDE (SR) 1000 MG TABLETS IP	EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
348	TENELIGLIPTIN 20 MG AND METFORMIN HYDROCHLORIDE (SR) 850 MG TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED
349	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & MENTHOL SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG MENTHOL IP 1.5 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED
350	RABEPRAZOLE GASRTO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS		Monday, October 04, 2004
351	ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS		Monday, June 26, 1905
352	PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE & CETIRIZINE DI-HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CETIRIZINE DI- HYDROCHLORIDE IP 5 MG EXCPIENTS Q.S. APPROVED COLOUR USED
353	GLIMEPIRIDE, PIOGLITAZONE AND METFORMIN HCl SUSTAINED RELEASE TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS GLIMEPIRIDE IP 2 MG PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, August 12, 2005
354	GLIMEPIRIDE, PIOGLITAZONE AND METFORMIN HCl SUSTAINED RELEASE TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS GLIMEPIRIDE IP 1 MG PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. APPROVED COLOUR USED		Friday, August 12, 2005
355	GLIMEPIRIDE TABLETS IP 1 MG	EACH UNCOATED TABLET CONTAINS GLIMEPIRIDE IP 1 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Sunday, January 24, 1999
356	PANTOPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE PROLONGED-RELEASE CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS PROLONGED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS	IP
357	PARACETAMOL PAEDIATRIC ORAL SUSPENSION IP	EACH 5 ML CONTAINS PARACETAMOL IP 125 MG EXCIPIENTS Q.S APPROVED COLOUR USED	IP
358	LEVOFLOXACIN TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVOFLOXACIN HEMIHYDRATE IP EQ. TO LEVOFLOXACIN 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Friday, July 23, 1999
359	ACECLOFENAC & THIOCOLCHICOSIDE TABLETS	EACH FILM COATED TABLET CONTAINS ACECLOFENAC IP 100 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S APPROVED COLOUR USED
360	OFLOXACIN AND ORNIDAZOLE TABLETS IP	EACH FILM COATED TABLET CONTAINS: OFLOXACIN IP 200 MG ORNIDAZOLE IP 500 MG EXCIPIENTS Q.S APPROVED COLOUR USED
361	PANTOPRAZOLE & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
362	DISODIUM HYDROGEN CITRATE SYRUP	EACH 5 ML CONTAINS: DISODIUM HYDROGEN CITRATE BP 1.53 GM FLAVOURED BASE Q.S. APPROVED COLOUR USED
363	ENTECAVIR TABLETS IP 1 MG	EACH FILM COATED TABLET CONTAINS ENTECAVIR IP 1 MG EXCIPIENTS Q.S APPROVED COLOUR USED		Monday, December 05, 2005
364	ENTECAVIR TABLETS IP 0.5 MG	EACH FILM COATED TABLET CONTAINS ENTECAVIR IP 0.5 MG EXCIPIENTS Q.S APPROVED COLOUR USED		Monday, December 05, 2005
365	OMEPRAZOLE GASTRO-RESISTANT CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS.		Monday, April 01, 1991
366	TERBINAFINE TABLETS IP 250 MG	EACH UNCOATED TABLET CONTAINS TERBINAFINE HYDROCHLORIDE IP EQ. TO TERBINAFINE 250 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Wednesday, March 29, 1995
367	TERBINAFINE TABLETS 500 MG	EACH UNCOATED TABLET CONTAINS TERBINAFINE HYDROCHLORIDE IP EQ. TO TERBINAFINE 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
368	DROTAVERINE HYDROCHLORIDE & MEFENAMIC ACID TABLETS	EACH UNCOATED TABLET CONTAINS: DROTAVERINE HYDROCHLORIDE IP 80 MG MEFENAMIC ACID IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
369	FEXOFENADINE HYDROCHLORIDE TABLETS IP 120 MG	EACH FILM COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Sunday, September 06, 1998
370	POVIDONE-IODINE OINTMENT USP	CONTAINS: POVIDONE-IODINE IP 10% W/W (AVAILABLE IODINE 1.0% W/W) WATER-SOLUBLE OINTMENT BASE Q.S.	USP	Wednesday, November 01, 1972
371	FEXOFENADINE HYDROCHLORIDE & MONTELUKAST TABLETS	EACH FILM-COATED TABLET CONTAINS FEXOFENADINE HYDROCHLORIDE IP 120 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Tuesday, August 31, 2010
372	DICLOFENAC SODIUM & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		Wednesday, January 30, 2008
373	ITRACONAZOLE CREAM 1% W/W	COMPOSITION ITRACONAZOLE BP 1.00% W/W METHYL PARABEN IP 0.10% W/W PROPYL PARABEN IP 0.025% W/W CREAM BASE Q.S.
374	POVIDONE-IODINE OINTMENT USP	CONTAINS: POVIDONE-IODINE IP 5 % W/W (AVAILABLE IODINE 1.0% W/W) WATER-SOLUBLE OINTMENT BASE Q.S.	USP	1972-November
375	ETORICOXIB & PARACETAMOL TABLETS	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 60 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
376	PARACETAMOL & MEFENAMIC ACID TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG MEFENAMIC ACID IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
377	OMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS OMEPRAZOLE IP 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS.	IP
378	PANTOPRAZOLE & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
379	PARACETAMOL & IBUPROFEN SUSPENSION	EACH 5 ML CONTAINS IBUPROFEN IP 100 MG PARACETAMOL IP 162.50 MG FLAVOURED SYRUP BASE Q.S. APPROVED COLOUR USED
380	MONTELUKAST SODIUM & LEVOCETIRIZINE HCL TABLETS	EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQUIVALENT TO MONTELUKAST 4 MG LEVOCETIRIZINE HYDROCHLORIDE IP 2.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
381	KETOCONAZOLE TABLETS IP 200 MG	EACH UNCOATED TABLET CONTAINS: KETOCONAZOLE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	1986-October
382	DICYCLOMINE HYDROCHLORIDE & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS DICYCLOMINE HYDROCHLORIDE IP 20 MG PARACETAMOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
383	PROCHLORPERAZINE MALEATE MOUTH DISSOLVING TABLET	EACH MOUTH DISSOLVING UNCOATED TABLET CONTAINS PROCHLORPERAZINE MALEATE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
384	OXCARBAZEPINE TABLETS IP 300 MG	EACH FILM -COATED TABLET CONTAINS OXCARBAZEPIN IP 300 MG EXCIPENTS Q.S. APPROVED COLOUR USED	IP	Monday, January 14, 2002
385	GABAPENTIN TABLETS IP	EACH FILM COATED TABLET CONTAINS GABAPENTIN IP 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
386	GABAPENTIN TABLETS IP	EACH FILM COATED TABLET CONTAINS: GABAPENTIN IP 300 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
387	PIRFENIDONE TABLETS IP 200 MG	EACH FILM COATED TABLET CONTAINS: PIRFENIDONE IP 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	9/14/2010
388	TICAGRELOR TABLETS IP 90 MG	EACH FILM COATED TABLET CONTAINS: TICAGRELOR IP 90 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	5/3/2012
389	DAPAGLIFLOZIN TABLETS 10 MG	EACH FILM COATED TABLET CONTAINS: DAPAGLIFLOZIN 200 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
390	TORSEMIDE TABLETS IP 20 MG	EACH UNCOATED TABLET CONTAINS: TORSEMIDE IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP
391	SITAGLIPTIN PHOSPHATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE IP EQ. TO SITAGLIPTIN 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		7/3/2010
392	SITAGLIPTIN PHOSPHATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: SITAGLIPTIN PHOSPHATE MONOHYDRATE IP EQ. TO SITAGLIPTIN 100 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	7/3/2010
393	GLICLAZIDE EXTENDED RELEASE TABLETS 60 MG	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS GLICLAZIDE IP 60 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		8/14/2007
394	GLICLAZIDE EXTENDED RELEASE TABLETS 120 MG	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS GLICLAZIDE IP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
395	GLICLAZIDE TABLETS IP 80 MG	EACH UNCOATED TABLET CONTAINS GLICLAZIDE IP 80 MG EXCIPIENTS Q.S. APPROVED COLOUR USED	IP	Nov. 1988
396	METOPROLOL SUCCINATE PROLONGED-RELEASE AND AMLODIPINE TABLETS IP	EACH UNCOATED BILAYERED TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) AMLODIPINE BESILATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	07 Feb. 2006
397	TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW		16 Jul. 2010
398	METOPROLOL SUCCINATE PROLONGED-RELEASE AND AMLODIPINE TABLETS IP	EACH FILM COATED BILAYERED TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) AMLODIPINE BESILATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	07 Feb. 2006
399	ROSUVASTATIN, ASPIRIN AND CLOPIDOGREL CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL.
400	ROSUVASTATIN, ASPIRIN AND CLOPIDOGREL CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL.
401	FLUOXETINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS FLUOXETINE HYDROCHLORIDE IP EQ. TO FLUOXETINE 40 MG EXCIPIENTS Q.S. COLOUR: PONCEAU 4 R
402	ZONISAMIDE TABLETS 100 MG	EACH FILM COATED TABLET CONTAINS ZONISAMIDE IP 100 MG COLOUR: TITANIUM DIOXIDE IP
403	CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE & MENTHOL SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HBr IP 10 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG MENTHOL IP 1.5 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: PONCEAU 4 R
405	GABAPENTIN & NORTRIPTYLINE HCL TABLETS	EACH FILM COATED TABLET CONTAINS GABAPENTIN IP 400 MG NORTRIPTYLINE HYDROCHLORIDE IP EQ. TO NORTRIPTYLINE 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
406	TAMSULOSIN HYDROCHLORIDE (MODIFIED RELEASE) DUTASTERIDE TABLETS	EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP		06 Feb. 2006
407	CHLORAMPHENICOL, BENZOCAINE AND PROPYLENE GLYCOL EAR DROPS	COMPOSITION EACH ML CONTAINS CHLORAMPHENICOL IP 5% W/V BENZOCAINE IP 1% W/V PROPYLENE GLYCOL IP Q.S. (AS BASE)
408	SUCRALFATE & OXETACAINE SUSPENSION	EACH 10 ML CONTAINS SUCRALFATE IP 1 G OXETACAINE BP 20 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW
409	DUTASTERIDE TABLETS 0.5 MG	EACH FILM COATED TABLET CONTAINS DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
410	DROTAVERINE HYDROCHLORIDE & MEFENAMIC ACID TABLETS	EACH UNCOATED TABLET CONTAINS DROTAVERINE HYDROCHLORIDE IP 80 MG MEFENAMIC ACID IP 250 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE
411	POVIDONE IODINE OINTMENT USP	COMPOSITION POVIDONE IODINE IP 5% W/W (0.5%W/W AVAILABLE IODINE) OINTMENT BASE Q.S.	USP	Sep. 1978
412	DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE & OXETACAINE SUSPENSION	EACH 5 ML CONTAINS DRIED ALUMINIUM HYDROXIDE IP 0.291 G MAGNESIUM HYDROXIDE IP 98 MG OXETACAINE BP 10 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE
413	HYDROXYZINE HYDROCHLORIDE SYRUP	EACH 5 ML CONTAINS HYDROXYZINE HYDROCHLORIDE IP 10 MG FLAVOURED SYRUPY BASE COLOUR: YELLOW OXIDE OF IRON
414	RIFAXIMIN TABLETS	EACH FILM COATED TABLET CONTAINS RIFAXIMIN BP 400 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		18 Jul. 2009
415	LEVETIRACETAM TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVETIRACETAM IP 750 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE OF YELLOW & TITANIUM DIOXIDE IP	IP	5-Apr-05
416	BILASTINE TABLETS	EACH UNCOATED TABLET CONTAINS BILASTINE 20 MG EXCIPIENTS Q.S.
417	DICLOFENAC POTASSIUM & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS DICLOFENAC POTASSIUM IP 50 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
418	AMBROXOL HCL, TERBUTALINE, GUAIPHENESIN AND MENTHOL SYRUP	EACH 5 ML CONTAINS AMBROXOL HYDROCHLORIDE IP 15 MG TERBUTALINE SULPHATE IP 1.25 MG GUAIPHENESIN IP 50 MG MENTHOL IP 2.5 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW		26-Mar-08
419	CETIRIZINE TABLETS	EACH FILM COATED TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP		12 Dec. 2002
420	LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP
421	CALCIUM CARBONATE & VITAMIN D3 TABLETS	EACH FILM-COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG (FROM AN ORGANIC SOURCE OYSTER SHELL) EQUIVALENT TO ELEMENTAL CALCIUM 500 MG VITAMIN D3 IP 500 IU EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TITANIUM DIOXIDE IP
422	METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 500 MG	EACH UNCOATED PROLONGED RELEASE TABLETS CONTAINES METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S.	IP	09 Nov. 2001
423	METFORMIN HYDROCHLORIDE PROLONGED RELEASE TABLETS IP 1000 MG	EACH UNCOATED PROLONGED RELEASE TABLETS CONTAINES METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S.	IP	2002
424	PARACETAMOL, CHLORPHENAMINE MALEATE AND PHENYLEPHRINE HCL TABLETS	EACH UNCOATED TABLETS CONTAINES: PARACETAMOL IP 325 MG CHLORPHENAMINE MALEATE IP 2 MG PHENYLEPHRINE HCL IP 10 MG EXCIPIENTS Q.S.
425	CITICOLINE TABLETS IP	EACH FILM COATED TABLETS CONTAINES CITICOLINE SODIUM IP EQUIVALENT TO CITICOLINE 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	31 Oct. 2008
426	ORLISTAT CAPSULES USP 120 MG	EACH HARD GELATIN CAPSULE CONTAINS ORLISTAT USP 120 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS	USP	22 Aug. 2007
427	PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S.
428	FLUPENTIXOL AND MELITRACEN TABLETS	EACH FILM COATED TABLETS CONTAINES FLUPENTIXOL HYDROCHLORIDE BP EQUIVALENT TO FLUPENTIXOL 0.5 MG MELITRACEN HYDROCHLORIDE EQUIVALENT TO MELITRACEN 10 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE		28 Oct. 1998
429	TELMISARTAN 40 MG AND CHLORTHALIDONE 6.25 MG TABLETS	EACH UNCOATED BILAYERED TABLETS CONTAINES TELMISARTAN IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
430	LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS LEVOCETIRIZINE DIHYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP	14 Jan. 2015
431	PHENYLEPHRINE HCL, CHLORPHENIRAMINE MALEATE AND SODIUM CITRATE SYRUP	EACH 5 ML CONTAINS PHENYLEPHRINE HCl IP 5 MG CHLORPHENIRAMINE MALEATE IP 2 MG SODIUM CITRATE IP 60 MG IN A FLAVOURED SYRUPY BASE Q.S. COLOUR: PONCEAU-4R
432	DIVALPROEX SODIUM EXTENDED RELEASE TABLETS IP 750 MG	EACH FILM-COATED EXTENDED RELEASE TABLET CONTAINS DIVALPROEX SODIUM IP EQ. TO VALPROIC ACID 750 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE BLACK & TITANIUM DIOXIDE IP	IP	25-Jun-04
433	ROXITHROMYCIN TABLETS IP 150 MG	EACH FILM COATED TABLET CONTAINS ROXITHROMYCIN IP 150 MG EXCIPIENTS Q.S. COLOUR: LAKE OF BRILLIANT BLUE & TITANIUM DIOXIDE IP	IP	27 Mar. 1992
434	LETROZOLE TABLETS IP 2.5 MG	EACH FILM COATED TABLET CONTAINS LETROZOLE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP	IP	11 Feb. 2002
435	RUPATADINE TABLETS 10 MG	EACH UNCOATED TABLET CONTAINS RUPATADINE FUMARATE IP EQ. TO RUPATADINE 10 MG EXCIPIENTS Q.S.		05 Apr. 2005
436	ATENOLOL TABLETS IP 50 MG	EACH UNCOATED TABLET CONTAINS ATENOLOL IP 50 MG EXCIPIENTS Q.S.	IP	Sep. 1985
437	ETORICOXIB TABLETS IP	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 90 MG EXCIPIENTS Q.S. COLOUR: PEA GREEN & TITANIUM DIOXIDE IP	IP
438	SODIUM PICOSULPHATE TABLETS 10 MG	EACH FILM COATED TABLET CONTAINS SODIUM PICOSULPHATE BP 10 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE		11 Feb. 1997
439	MOXIFLOXACIN HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS MOXIFLOXACIN HCl IP EQ. TO MOXIFLOXACIN 400 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP	6-Jun-01
440	PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S.		13 Oct. 2010
441	ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 20 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG (AS IMMEDIATE-RELEASE PELLETS) DOMPERIDONE IP 20 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS
442	METFORMIN HYDROCHLORIDE PROLONGED-RELEASE AND GLIMEPIRIDE TABLETS IP	EACH UNCOATED BILAYERED TABLET CONTAINS METFORMIN HCL IP 1000 MG (IN PROLONGED-RELEASE FROM) GLIMEPIRIDE IP 2 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE	IP	8-Jun-07
443	METFORMIN HYDROCHLORIDE PROLONGED-RELEASE AND GLIMEPIRIDE TABLETS IP	EACH UNCOATED BILAYERED TABLET CONTAINS METFORMIN HCL IP 1000 MG (IN PROLONGED-RELEASE FROM) GLIMEPIRIDE IP 1 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW	IP	8-Jun-07
444	TELMISARTAN TABLETS IP 40 MG	EACH UNCOATED TABLET CONTAINS TELMISARTAN IP 40 MG EXCIPIENTS Q.S.	IP	25 Nov. 2002
445	TELMISARTAN AND HYDROCHLORTHIAZIDE TABLETS IP	EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG HYDROCHLORTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON	IP	29 Aug. 2003
446	VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS VILDAGLIPTIN 50 MG METFORMIN HCL IP 500 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP		21 Jul. 2008
447	VILDAGLIPTIN TABLETS	EACH UNCOATED TABLET CONTAINS VILDAGLIPTIN 50 MG EXCIPIENTS Q.S.		25 Jul. 2008
448	ESOMEPRAZOLE 40 MG (EC) & ITOPRIDE HYDROCHLORIDE 150 MG (SR) CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HCl IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS.		13-Nov-06
449	PANTOPRAZOLE 40 MG (EC) & ITOPRIDE HYDROCHLORIDE 150 MG (SR) CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HCl IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS.		8-Apr-06
450	ESOMEPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 10 MG (AS IMMEDIATE-RELEASE PELLETS) DOMPERIDONE IP 20 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS
451	ITOPRIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	9-May-02
452	ITOPRIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 150 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP
453	RANITIDINE ORAL SOLUTION IP	EACH 5 ML CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 75 MG FLAVOURED SYRUP BASE COLOUR: QUINOLINE YELLOW WS	IP
454	CITICOLINE AND PIRACETAM TABLETS	EACH FILM COATED TABLET CONTAINS CITICOLINE SODIUM IP EQ. TO CITICOLINE 500 MG PIRACETAM IP 800 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
455	PREGABALIN SUSTAINED RELEASE & METHYLCOBALAMIN TABLETS	EACH UNCOATED TABLETS CONTAINS PREGABALIN IP 75 MG (IN SUSTAINED RELEASE FORM) METHYLCOBALAMIN IP 1500 MCG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON		9-Feb-10
456	CHLORPHENIRAMINE MALEATE & PHENYLEPHRINE HYDROCHLORIDE SYRUP	EACH 5 ML CONTAINS CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCl IP 5 MG IN A FLAVOURED SYRUP BASE COLOUR:PANCEAU 4R
457	FERACRYLUM GEL 1 % W/W	COMPOSITION FERACRYLUM 1 % W/W WATER MISCIBLE BASE Q.S.
458	TAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE AND DEFLAZACORT CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS FILM COATED MODIFIED RELEASE TABLETS) COLOUR: TITANIUM DIOXIDE IP DEFLAZACORT 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL
459	DICYCLOMINE HYDROCHLORIDE & PARACETAMOL CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS DICYCLOMINE HCl IP 20 MG PARACETAMOL IP 325 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL
460	CETIRIZINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS CETIRIZINE HYDROCHLORIDE IP 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP
461	PARACETAMOL, PHENYLEPHRINE HCl, CAFFEINE AND DIPHENHYDRAMINE HCl TABLETS	EACH FILM COATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE Hcl IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE Hcl IP 25 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE		10/13/2010
462	TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS IP 2 MG	EACH UNCOATED TABLET CONTAINS TRIHEXYPHENIDYL HYDROCHLORIDE IP 2 MG EXCIPIENTS Q.S.	IP
463	BENZHEXOL HYDROCHLORIDE TABLETS IP	EACH UNCOATED TABLET CONTAINS BENZHEXOL HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S.	IP
464	PARACETAMOL AND THIOCOLCHICOSIDE TABLETS	EACH FILM COATED TABLET CONTAINS PARACETAMOL IP 325 MG THIOCOLCHICOSIDE IP 4 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE
465	ATORVASTATIN TABLETS IP 80 MG	EACH FILM COATED TABLET CONTAIN ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 80 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	2/25/2008
466	DEXLANSOPRAZOLE MODIFIED RELEASE AND DOMPERIDONE SUSTAINED RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 30 MG (AS MODIFIED RELEASE PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS.
467	DEXLANSOPRAZOLE MODIFIED RELEASE AND DOMPERIDONE SUSTAINED RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 60 MG (AS MODIFIED RELEASE PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS.
468	DEXLANSOPRAZOLE MODIFIED RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 60 MG (AS MODIFIED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS.		1/16/2017
469	MONTELUKAST SODIUM AND DESLORATADINE TABLETS	EACH FILM COATED TABLET CONTAINS MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG DESLORATADINE BP 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
470	DEXLANSOPRAZOLE MODIFIED RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS DEXLANSOPRAZOLE IP 30 MG (AS MODIFIED RELEASE PELLETS) APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS.		1/16/2017
471	VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE (SR) TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS VILDAGLIPTIN 50 MG METFORMIN HCL IP 500 MG (AS SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW		21 JUL. 2008
472	TELMISARTAN & CHLORTHALIDONE TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS TELMISARTAN IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE RED & FERRIC OXIDE YELLOW
473	METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	11/29/2004
474	METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS IP	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP	IP	11/29/2004
475	L-ORNITHINE L-ASPARTATE TABLETS 500 MG	EACH FILM COATED TABLET CONTAINS L-ORNITHINE L-ASPARTATE 500 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP
476	L-ORNITHINE- L-ASPARTATE SYRUP	EACH 5 ML CONTAINS L-ORNITHINE- L-ASPARTATE 250 MG IN FLAVOURE SYRUPY BASE Q.S.
477	LIQUID PARAFFIN & MILK OF MAGNESIA ORAL EMULSION	EACH 15 ML CONTAINS: LIQUID PARAFFIN IP 3.75 ML MILK OF MAGNESIA IP 11.25 ML IN A FLAVOURED SYRUP BASE Q.S. COLOUR: CARMOSINE & PONCEAU 4R
478	RUPATADINE TABLETS 10 MG	EACH UNCOATED TABLET CONTAINS RUPATADINE FUMARATE IP EQ. TO RUPATADINE 10 MG EXCIPIENTS Q.S.		05 APR. 2005
479	ATENOLOL TABLETS IP 50 MG	EACH UNCOATED TABLET CONTAINS ATENOLOL IP 50 MG EXCIPIENTS Q.S.	IP	SEP. 1985
480	ETORICOXIB TABLETS IP	EACH FILM COATED TABLET CONTAINS ETORICOXIB IP 90 MG EXCIPIENTS Q.S. COLOUR: PEA GREEN & TITANIUM DIOXIDE IP	IP
481	SODIUM PICOSULPHATE TABLETS 10 MG	EACH FILM COATED TABLET CONTAINS SODIUM PICOSULPHATE BP 10 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE		11 FEB. 1997
482	MOXIFLOXACIN HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS MOXIFLOXACIN HCL IP EQ. TO MOXIFLOXACIN 400 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP	06IP	6-Jun-01
483	PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 5 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS		13 OCT. 2010
484	PREGABALIN 75 MG (PROLONGED RELEASE) AND ETORICOXIB TABLETS	EACH FILM COATED BILAYERED TABLET CONTAINS PREGABALIN IP 75 MG (AS PROLONGED RELEASE) ETORICOXIB IP 60 MG EXCIPIENTS Q.S. COLOUR: ERYTHROSINE
485	TAMSULOSIN HYDROCHLORIDE (MODIFIED RELEASE) DUTASTERIDE TABLETS	EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) DUTASTERIDE IP 0.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP		06 FEB. 2006
486	DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE AND PHENYLEPHRINE HYDROCHLORIDE FLAVOURED DISPERSIBLE TABLETS	EACH UNCOATED FLAVOURED DISPERSIBLE TABLET CONTAINS DEXTROMETHORPHAN HBR IP 10 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HCL IP 5 MG EXCIPIENTS Q.S.
487	BILASTINE & MONTELUKAST TABLETS	EACH FILM COATED TABLET CONTAINS BILASTINE 20 MG MONTELUKAST SODIUM IP EQ. TO MONTELUKAST 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
488	OMEPRAZOLE MAGNESIUM TABLETS	EACH ENTERIC COATED TABLET CONTAINS OMEPRAZOLE MAGNESIUM IP EQ. TO OMEPRAZOLE 40 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
489	METHYLPREDNISOLONE TABLETS IP	EACH UNCOATED TABLET CONTAINS: METHYLPREDNISOLONE IP 16 MG EXCIPIENTS Q.S.	IP
490	METHYLPREDNISOLONE TABLETS IP	EACH UNCOATED TABLET CONTAINS: METHYLPREDNISOLONE IP 8 MG EXCIPIENTS Q.S.	IP	9/1/2009
491	CARISOPRODOL TABLETS IP 350 MG	EACH UNCOATED TABLET CONTAINS: CARISOPRODOL IP 350 MG EXCIPIENTS Q.S.	IP
492	MIRTAZAPINE TABLETS IP 15 MG	EACH FILM COATED TABLET CONTAINS: MIRTAZAPINE IP 15 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE	IP	2/13/2001
493	RIFAXIMIN TABLETS	EACH FILM COATED TABLET CONTAINS: RIFAXIMIN BP 550 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF & TITANIUM DIOXIDE IP		8/18/2011
494	DEFLAZACORT SUSPENSION	EACH 5 ML CONTAINS: DEFLAZACORT 6 MG IN A FLAVOURED SYRUPY BASE Q.S. COLOUR: QUINOLINE YELLOW		6/15/2007
495	CHLORHEXIDINE GLUCONATE 0.2% AND MENTHOL 0.1% MOUTH WASH	COMPOSITION CHLORHEXIDINE GLUCONATE SOLUTION IP EQ. TO CHLORHEXIDINE GLUCONATE 0.20 % W/W MENTHOL 0.10 % W/W AQUEOUS BASE Q.S. COLOUR: BRILLIANT BLUE
496	GLICLAZIDE (MR) AND METFORMIN HYDROCHLORIDE (SR) TABLETS	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 30 MG (AS MODIFIED RELEASED) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) COLOUR: QUINILINE YELLOW		4/27/2005
497	GLICLAZIDE (MR) AND METFORMIN HYDROCHLORIDE (SR) TABLETS	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS MODIFIED RELEASED) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) COLOUR: ERYTHROSINE		4/27/2005
498	GLICLAZIDE (SR), METFORMIN HYDROCHLORIDE (SR) & PIOGLITAZON TABLETS	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS SUSTAINED RELEASE FORM) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZON 15 MG COLOUR: QUINILINE YELLOW		5/28/2010
499	GLICLAZIDE (SR), METFORMIN HYDROCHLORIDE (SR) & PIOGLITAZON TABLETS	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLICLAZIDE IP 60 MG (AS SUSTAINED RELEASE FORM) METFORMIN HYDROCHLORIDE IP 500 MG (AS SUSTAINED RELEASE FORM) PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZON 15 MG COLOUR: SUNSET YELLOW		5/28/2010
500	DICLOFENAC TABLETS IP	EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM IP 50 MG EXCIEPINTS Q.S.	IP	SEP. 1985
501	PARACETAMOL, PHENYLEPHRINE HCL & CHLORPHENIRAMINE MALEATE SUSPENSION	EACH 5 ML CONTAINS PARACETAMOL IP 125 MG PHENYLEPHRINE HCL IP 5 MG CHLORPHENIRAMINE MALEATE IP 1 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW FCF
502	CALCIUM CARBONATE, VITAMIN D3, METHYLCOBALAMIN, L-METHYLFOLATE CALCIUM & PYRIDOXAL-5-PHOSPHATE TABLETS	EACH FILM COATED TABLET CONTAINS CALCIUM CARBONATE IP 1250 MG VITAMIN D3 IP 2000 IU METHYLCOBALAMIN IP 1500 MCG CALCIUM L-5-METHYLTETRAHYDROFOLATE USP 1 MG (L-METHYLFOLATE CALCIUM) PYRIDOXAL-5-PHOSPHATE 20 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
503	FRUSEMIDE TABLETS IP 40 MG	EACH UNCOATED TABLETS CONTAINS FRUSEMIDE IP 40 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP
504	PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 25 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS
505	LOXAPINE CAPSULES USP	EACH HARD GELATIN CAPSULE CONTAINS: LOXAPINE SUCCINATE USP EQ. TO LOXAPINE 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL AND PELLETS	USP	SEP. 1990
506	GLIPIZIDE TABLETS IP 5 MG	EACH UNCOATED TABLET CONTAINS GLIPIZIDE IP 5 MG EXCIPIENTS Q.S.	IP	21.08. 1996
507	CINNARIZINE TABLETS IP	EACH FILM COATED TABLET CONTAINS CINNARIZINE IP 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP	AUG. 1985
508	CHLORAMPHENICOL CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS CHLORAMPHENICOL IP 500 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS	IP	OCT. 1972
509	ESCITALOPRAM OXALATE TABLETS IP	EACH FILM COATED TABLET CONTAINS ESCITALOPRAM OXALATE IP EQ. TO ESCITALOPRAM 20 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON	IP
510	METOPROLOL SUCCINATE & RAMIPRIL TABLETS	EACH FILM COATED TABLET CONTAINS METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG RAMIPRIL IP 2.5 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW		26.02.07
511	CARVEDILOL EXTENDED RELEASE TABLETS 10 MG	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 10 MG EXCIPIENTS Q.S
512	CARVEDILOL EXTENDED RELEASE TABLETS 20 MG	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 20 MG EXCIPIENTS Q.S.
513	ITOPRIDE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS ITOPRIDE HYDROCHLORIDE IP 50 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP	09.05.02
514	CARVEDILOL EXTENDED RELEASE TABLETS 25 MG	EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS CARVEDILOL IP 25 MG EXCIPIENTS Q.S.
515	NORTRIPTYLINE TABLETS IP	EACH FILM COATED TABLET CONTAINS NORTRIPTYLINE HYDROCHLORIDE IP EQ.TO NORTRIPTYLINE 25 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP
516	PIROXICAM DISPERSIBLE TABLETS 20 MG	EACH UNCOATED DISPERSIBLE TABLET CONTAINS PIROXICAM IP 20 MG (IN A FLAVORED BASE) EXCIPIENTS Q.S.
517	RANITIDINE TABLETS IP 150 MG	EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 150 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW	IP
518	PREDNISOLONE TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS PREDNISOLONE IP 10 MG EXCIPIENTS Q.S.	IP	DEC. 1971
519	CINNARIZINE & DOMPERIDONE TABLETS	EACH FILM COATED TABLET CONTAINS CINNARIZINE IP 20 MG DOMPERIDONE IP 15 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE YELLOW		FEB. 1992
520	DIACEREIN CAPSULES IP 50 MG	EACH HARD GELATIN CAPSULE CONTAINS DIACEREIN IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS	IP	2004
521	GLIBENCLAMIDE TABLETS IP 5 MG	EACH UNCOATED TABLET CONTAINS GLIBENCLAMIDE IP 5 MG EXCIPIENTS Q.S.	IP
522	HALOPERIDOL TABLETS IP 5 MG	EACH UNCOATED TABLET CONTAINS HALOPERIDOL IP 5 MG EXCIPIENTS Q.S.	IP
523	AMBROXOL HYDROCHLORIDE & LEVOCETIRIZINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS AMBROXOL HYDROCHLORIDE IP 60 MG LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW
524	SALBUTAMOL TABLETS IP 2 MG	EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 2 MG EXCIPIENTS Q.S.	IP
525	SALBUTAMOL TABLETS IP 4 MG	EACH UNCOATED TABLET CONTAINS SALBUTAMOL SULPHATE IP EQ. TO SALBUTAMOL 4 MG EXCIPIENTS Q.S.	IP
526	RANITIDINE & DOMPERIDONE TABLETS	EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQ. TO RANITIDINE 150 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. COLOUR: SUSET YELLOW
527	BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN PARACETAMOL, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE & TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 325 MG BROMHEXINE HYDROCHLORIDE IP 8 MG CHLORPHENIRAMINE MALEATE IP 2 MG PHENYLEPHRINE HYDROCHLORIDE IP 10 MG GUAIPHENESIN IP 100 MG EXCIPIENTS Q.S.
528	DISULFIRAM TABLETS IP 500 MG	EACH UNCOATED TABLET CONTAINS DISULFIRAM IP 500 MG EXCIPIENTS Q.S.	IP
529	AZELNIDIPINE TABLETS IP 8 MG	EACH UNCOATED TABLET CONTAINS AZELNIDIPINE IP 8 MG EXCIPIENTS Q.S.	IP
530	FURAZOLIDONE & METRONIDAZOLE TABLETS	EACH UNCOATED TABLET CONTAINS FURAZOLIDONE IP 100 MG METRONIDAZOLE IP 200 MG EXCIPIENTS Q.S.
531	INDOMETHACIN CAPSULE IP 25 MG	EACH HARD GELATIN CAPSULE CONTAINS : INDOMETHACIN IP 25 MG APPROVED COLOUR USED	IP
532	SILDENAFIL CITRATE AND DAPOXETINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS : SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 50 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S.
533	PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, SODIUM CITRATE, DEXTROMETHORPHAN HYDROBROMIDE & MENTHOL SUSPENSION	EACH 5 ML CONTAINS PARACETAMOL IP 250 MG PHENYLEPHRINE HYDROCHLORIDE IP 5 MG CETIRIZINE HYDROCHLORIDE IP 2.5 MG SODIUM CITRATE IP 25 MG DEXTROMETHORPHAN HYDROBROMIDE IP 5 MG MENTHOL IP 1 MG FLAVOURED PALATABLE BASE Q.S. COLOUR: SUNSET YELLOW FCF
534	NIMESULIDE FLAVOURED DISPERSIBLE TABLETS 100 MG	EACH UNCOATED DISPERSIBLE TABLETS CONTAINS NIMESULIDE BP 100 MG EXCIPIENTS Q.S. NOT FOR USE BELOW 12 YEARS OF AGE
535	DAPOXETINE HYDROCHLORIDE IP 60 MG AND SILDENAFIL CITRATE IP 100 MG TABLETS	EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 60 MG SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 100 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE
536	SPIRONOLACTONE TABLETS IP	EACH UNCOATED TABLET CONTAINS SPIRONOLACTONE IP 25 MG EXCIPIENTS Q.S.	IP
537	TORSEMIDE TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 10 MG EXCIPIENTS Q.S.	IP
538	NIFEDIPINE SR TABLETS IP 20 MG	EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS NIFEDIPINE IP 20 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW	IP	NOV. 1989
539	TORSEMIDE & SPIRONOLACTONE TABLETS	EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 10 MG SPIRONOLACTONE IP 25 MG EXCIPIENTS Q.S.
540	CHLORTHALIDONE TABLETS IP	EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW	IP
541	CHLORTHALIDONE, TELMISARTAN & AMLODIPINE TABLETS	EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 6.25 MG TELMISARTAN IP 40 MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
542	AMLODIPINE AND CHLORTHALIDONE TABLETS	EACH FILM TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG CHLORTHALIDONE IP 12.5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
543	NAPROXEN SODIUM & DOMPERIDONE TABLETS	EACH FILM COATED BILAYER TABLET CONTAINS NAPROXEN SODIUM BP 500 MG DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
544	AMISULPRIDE TABLETS	EACH UNCOATED TABLET CONTAINS AMISULPRIDE IP 200 MG EXCIPIENTS Q.S.		12.03.10
545	ETODOLAC EXTENDED RELEASE TABLETS IP	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS ETODOLAC 600 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE	IP
546	TOLPERISONE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS TOLPERISONE HYDROCHLORIDE 150 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE		01.10.2008
547	DAPOXETINE HYDROCHLORIDE IP TABLETS 30 MG	EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE	IP	15.11.2010
548	DAPOXETINE HYDROCHLORIDE IP TABLETS 60	EACH FILM COATED TABLET CONTAINS DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 60 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE & TARTRAZINE	IP	15.11.2010
549	PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS Q.S.		13.10.2010
550	SUCRALFATE & OXETACAINE SUSPENSION	EACH 5 ML CONTAINS SUCRALFATE IP 500 MG OXETACAINE BP 10 MG FLAVOURED SYRUPY BASE Q.S		KOKATE SR. 112 17.07.2015
551	SILVER SULFADIAZINE & CHLORHEXIDINE GLUCONATE CREAM	COMPOSITION SILVER SULFADIAZINE IP 1.00 % W/W CHLORHEXIDINE GLUCONATE SOLUTION IP 0.20 % W/W CHLOROCRESOL IP 0.10 % W/W (AS PRESERVATIVE) CREAM BASE Q.S.		06.07.2017
552	PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE AND DIPHENHYDRAMINE HCL TABLETS	EACH UNCOATED TABLET CONTAINS PARACETAMOL IP 500 MG PHENYLEPHRINE HCL IP 10 MG CAFFEINE (ANHYDROUS) IP 30 MG DIPHENHYDRAMINE HCL IP 25 MG EXCIPIENTS Q.S.
553	BACLOFEN EXTENDED RELEASE CAPSULES	EACH EXTENDED RELEASE (GRS) CAPSULE CONTAINS BACLOFEN IP 30 MG APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL.		01.08.2006
554	BETAHISTINE HCl TABLETS IP 16 MG	EACH UNCOATED TABLET CONTAINS BETAHISTINE HYDROCHLORIDE IP 16 MG EXCIPIENTS Q.S.	IP	20.01.2000
555	RABEPRAZOLE (EC) & ITOPRIDE HYDROCHLORIDE (SR) CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS RABEPRAZOLE SODIUM IP 20 MG (AS ENTERIC COATED PELLETS) ITOPRIDE HYDROCHLORIDE IP 150 MG (AS SUSTAINED RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS.		28.11.2006
556	ESOMEPRAZOLE ENTERIC COATED AND LEVOSULPIRIDE SUSTAINED-RELEASE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) LEVOSULPIRIDE IP 75 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY CAPSULES SHELL AND PELLETS		13.02.2014
557	ERGOTAMINE TARTRATE, CAFFEINE, PARACETAMOL & PROCHLORPERAZINE MALEATE TABLETS	EACH FILM COATED TABLET CONTAINS ERGOTAMINE TARTRATE IP 1 MG CAFFEINE (MONOHYDRATE) IP 100 MG PARACETAMOL IP 250 MG PROCHLORPERAZINE MALEATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
558	DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE & MENTHOL SYRUP	EACH 5 ML CONTAINS DEXTROMETHORPHAN HYDROBROMIDE IP 10 MG CHLORPHENIRAMINE MALEATE IP 4 MG MENTHOL IP 2 MG FLAVOURED SYRUPY BASE Q.S. COLOUR: SUNSET YELLOW
559	BISOPROLOL FUMARATE & AMLODIPINE BESYLATE TABLETS	EACH UNCOATED TABLET CONTAIN BISOPROLOL FUMARATE IP 2.5MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S.		22.07.2005
560	BISOPROLOL FUMARATE & AMLODIPINE BESYLATE TABLETS	EACH UNCOATED TABLET CONTAIN BISOPROLOL FUMARATE IP 5MG AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S COLOUR: TITANIUM DIOXIDE IP		30.11.2005
561	AMLODIPINE AND HYDROCHLOROTHIAZI-DE TABLETS	EACH UNCOATED TABLET CONTAIN AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S.		14.04.2004
562	CILNIDIPINE TABLETS IP	EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 5 MG EXCIPIENTS Q.S COLOUR : IRON OXIDE YELLOW & TITANIUM DIOXIDE	IP	21.06.2007
563	CILNIDIPINE TABLETS IP	EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 10 MG EXCIPIENTS Q.S COLOUR : IRON OXIDE YELLOW & TITANIUM DIOXIDE	IP	21.06.2007
564	CILNIDIPINE TABLETS IP	EACH FILM COATED TABLET CONTAINS: CILNIDIPINE IP 20 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE	IP
565	ATORVASTATIN TABLETS IP 40 MG	EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG EXCIPIENTS Q.S COLOUR : TITANIUM DIOXIDE IP	IP	17.09.1999
566	ATORVASTATIN AND ASPIRIN CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG ASPIRIN IP 75 MG (AS GASTRO RESISTANT TABLLET) APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS		18.01.2008
567	ATORVASTATIN 10 MG AND FENOFIBRATE 160 MG IP TABLETS	EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG FENOFIBRATE IP 160 MG COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP	IP	24.12.2004
568	ATORVASTATIN AND CLOPIOGREL TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10MG CLOPIOGREL BISULPHATE IP EQ. TO CLOPIOGREL 75MG EXCIPIENT Q.S. COLOUR : RED OXIDE OF IRON		KOKATE SR. 2189 13.10.2016
569	LOSARTAN & HYDROCHLORO-THIAZIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS: LOSARTAN POTASSIUM IP 50 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR:TITANIUM DIOXIDE IP	IP	08.06.1999
570	ROSUVASTATIN TABLETS IP 40 MG	EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 40 MG EXCIPIENTS Q.S. COLOURS : RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP	08.11.2008
571	ROSUVASTATIN AND FENOFIBRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 10 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOURS : RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP	29.12.2010
572	ROSUVASTATIN AND FENOFIBRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSVASTATIN 20 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOURS : TITANIUM DIOXIDE IP	IP	23.08.2010
573	METOPROLOL SUCCINATE EXTENDED RELEASE TABLET IP 12.5 MG	EACH FILM COATED EXTENDED RELEASE TABLET CONTAIN : METOPROLOL SUCCINATE IP 11.875 MG EQ. TO METOPROLOL TARTRATE 12.5 MG EXCIPIENT Q.S. COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE	IP	15.04.2005
574	METOPROLOL PROLONGED RELEASE TABLETS IP	EACH FILM COATED PROLONGED RELEASE TABLET CONTAIN : METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG EXCIPIENT Q.S. COLOUR : TITANIUM DIOXIDE IP	IP	30.10.2002
575	METOPROLOL PROLONGED RELEASE TABLETS IP	EACH FILM COATED PROLONGED RELEASE TABLET CONTAIN METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG EXCIPIENT Q.S. COLOUR : TITANIUM DIOXIDE IP	IP	30.10.2002
576	TENELIGLIPTIN TABLETS 20 MG	EACH FILM COATED TABLET CONTAINS: TENELIGLIPTIN HYDROBROMIDE HYDRATE IP EQ. TO TENELIGLIPTIN 20 MG EXCIPIENTS Q.S. COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP		18.05.2015
577	METFORMIN HYDROCHLORIDE SUSTAINED RLEASE TABLET IP	EACH UNCOATED SUSTAINED RELEASE TABLET CONTAIN : METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS	IP	2002
578	VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE (SUSTAINED RELEASE) TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS: VOGLIBOSE IP 0.3 MG GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USPNF YELLOW & FERRIC OXIDE USP NF RED		14.01.2020
579	VOGLIBOSE, GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE (SUSTAINED RELEASE) TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS: VOGLIBOSE IP 0.2 MG GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USPNF YELLOW & FERRIC OXIDE USP NF RED		14.01.2020
580	VOGLIBOSE TABLET IP 0.2 MG	EACH UNCOATED TABLET CONTAINS: VOGLIBOSE IP 0.2 MG EXCIPIENTS Q.S.	IP	17.11.2005
581	VOGLIBOSE TABLET IP 0.3 MG	EACH UNCOATED TABLET CONTAINS: VOGLIBOSE IP 0.3 MG EXCIPIENTS Q.S.	IP	17.11.2005
582	RAMIPRIL TABLETS IP	EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW IRON OXIDE	IP	2005
583	RAMIPRIL TABLETS IP	EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 5 MG EXCIPIENTS Q.S	IP	2005
584	VILDAGLIPTIN AND METFORMIN HYDROCHLORIDE TABLET	EACH FILM COATED TABLET CONTAINS VILDAGLIPTIN IP 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & YELLOW OXIDE OF IRON		21.07.2008
585	SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET	EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & RED OXIDE OF IRON		28.04.2008
586	SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET	EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25 MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP & RED OXIDE OF IRON		28.04.2008
587	BISOPROLOL FUMARATE TABLET USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP	USP	19.01.2001
588	BISOPROLOL FUMARATE TABLET USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP	USP	27.02.1992
589	BISOPROLOL FUMARATE TABLET USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 10 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP	USP	27.02.1992
590	DOXOFYLLINE AND AMBROXOL HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS DOXOFYLLINE IP 400 MG AMBROXOL HYDROCHLORIDE IP 30 MG EXCIPIENTS Q.S.		23.12.2009
591	DICLOFENAC SODIUM & PARACETAMOL TABLETS	EACH UNCOATED TABLET CONTAINS: DICLOFENAC SODIUM IP 50 MG PARACETAMOL IP 250 MG EXCIPIENTS Q.S.
592	PARACETAMOL AND CAFFEINE TABLET IP	EACH UNCOATED TABLET CONTAINS: PARACETAMOL IP 500 MG CAFFEINE IP EQ. ANHYDROUS CAFFEINE 50 MG EXCIPIENTS Q.S.
593	TELMISARTAN TABLET IP 80 MG	EACH UNCOATED TABLET CONTAINS: TELMISARTAN IP 80 MG EXCIPIENTS Q.S.	IP	14.05.2010
594	GLIMEPIRIDE TABLET IP 3 MG	EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 3 MG EXCIPIENT Q.S. COLOUR: YELLOW OXIDE OF IRON	IP	24.01.1999
595	GLIMEPIRIDE TABLET IP 4 MG	EACH FILM COATED TABLET CONTAINS: GLIMEPIRIDE IP 4MG EXCIPIENT Q.S. COLOUR: QUINOLINE YELLOW	IP	24.01.1999
596	RABEPRAZOLE SODIUM TABLET 40 MG	EACH ENTERIC COATED TABLET CONTAINS: RABEPRAZOLE SODIUM IP 40 MG COLOUR : YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP
597	GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLIMEPIRIDE IP 3 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON	IP
598	GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH UNCOATED BILAYERED TABLETS CONTAINS GLIMEPIRIDE IP 4 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON	IP
599	GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP
600	GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 3 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP
601	GLIMEPIRIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH FILM COATED TABLETS CONTAINS GLIMEPIRIDE IP 4 MG METFORMIN HYDROCHLORIDE IP 850 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON & TITANIUM DIOXIDE IP	IP
602	PIOGLITAZONE HYDROCHLORIDE TABLET IP	EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG EXCIPIENTS Q.S.	IP	17.10.2000
603	PIOGLITAZONE HYDROCHLORIDE TABLET IP	EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 30 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON	IP	17.10.2000
604	PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (SR) TABLET	EACH UNCOATED TABLET CONTAINS PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON
605	DICLOFENAC SODIUM SUSTAINED RELEASE TABLET IP	EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS DICLOFENAC SODIUM IP 75MG EXCIPIENTS Q.S. COLOUR : IRON OXIDE RED & TITANIUM DIOXIDE IP	IP
606	DICLOFENAC SODIUM SUSTAINED RELEASE TABLET IP	EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS DICLOFENAC SODIUM IP 150 MG EXCIPIENTS Q.S. COLOUR : IRON OXIDE RED & TITANIUM DIOXIDE IP	IP
607	ROSUVASTATIN TABLET IP	EACH FILM COATED TABLET CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG EXCIPIENTS Q.S. COLOUR : FERRIC OXIDE & TITANIUM DIOXIDE IP	IP	08.11.2008
608	ROSUVASTATIN TABLET IP	EACH FILM COATED TABLET CONTAINS ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 40 MG EXCIPIENTS Q.S. COLOUR : FERRIC OXIDE & TITANIUM DIOXIDE IP	IP	08.11.2008
609	DAPAGLIFLOZIN TABLETS 10 MG	EACH FILM COATED TABLETS CONTAINS DAPAGLIFLOZIN 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED		25.02.2015
610	PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (SR) TABLET	EACH UNCOATED TABLET CONTAINS: PIOGLITAZONE HYDROCHLORIDE IP EQ. TO PIOGLITAZONE 15 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN A SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON		18.10.2002
611	ROSUVASTATIN AND CLOPIDOGREL TABLET	EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG CLOPIDOGREL BISULPHATE IP EQ. CLOPIDOGREL 75 MG EXCIPIENT Q.S. COLOUR: FERRIC OXIDE & TITANIUM DIOXIDE IP
612	ROSUVASTATIN AND CLOPIDOGREL TABLET	EACH FILM COATED TABLET CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP EQ. CLOPIDOGREL 75 MG EXCIPIENT Q.S. COLOUR: FERRIC OXIDE , TITANIUM DIOXIDE IP
613	ATORVASTATIN TABLETS IP	EACH FILM COATED TABLET CONTAINS: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 5 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE & TITANIUM DIOXIDE IP	IP	30.10.2001
614	ATORVASTATIN TABLETS IP	EACH FILM COATED TABLET CONTAINS:: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE & TITANIUM DIOXIDE IP	IP	20.04.2011
615	ATORVASTATIN & FENOFIBRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS:: ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 10 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP	IP
616	ATORVASTATIN & FENOFIBRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 20 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP	IP
617	ATORVASTATIN & FENOFIBRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS: : ATORVASTATIN CALCIUM IP EQ. TO ATORVASTATIN 40 MG FENOFIBRATE IP 160 MG EXCIPIENTS Q.S. COLOUR: LAKE INDIGO CARMINE & TITANIUM DIOXIDE IP	IP
618	BISOPROLOL FUMARATE TABLETS USP	EACH FILM COATED TABLET CONTAINS: BISOPROLOL FUMARATE USP 5 MG COLOUR : FERRIC OXIDE USP NF& TITANIUM DIOXIDE IP	USP	27.02.1992
619	BISOPROLOL FUMARATE TABLETS USP	EACH FILM COATED TABLET CONTAINS: BISOPROLOL FUMARATE USP 2.5 MG COLOUR : FERRIC OXIDE USP NF& TITANIUM DIOXIDE IP	USP	13.05.1999
620	DRIED ALUMINIUM HYDROXIDE, MAGNESIUM ALUMINIUM SILICATE HYDRATE, MAGNESIUM HYDROXIDE & SIMETHICONE TABLETS	EACH UNCOATED CHEWABLE TABLET CONTAINS: DRIED ALUMINIUM HYDROXIDE GEL IP 300 MG MAGNESIUM ALUMINIUM SILICATE HYDRATE 50 MG MAGNESIUM HYDROXIDE IP 25 MG SIMETHICONE IP 25 MG COLOUR :SUNSET YELLOW FCF
621	ASPIRIN GASTRO-RESISTANT TABLET IP 75 MG	EACH GASTRO-RESISTANT TABLET CONTAINS:: ASPIRIN IP 75 MG COLOUR: LAKE OF SUNSET YELLOW FCF & TITANIUM DIOXIDE IP	IP
622	FOLIC ACID TABLET IP 5 MG	EACH UNCOATED TABLET CONTAINS: FOLIC ACID IP 5 MG EXCIPIENT Q.S.	IP
623	HYDROXYCHLOROQUINE TABLETS IP	EACH FILM COATED TABLET CONTAINS: HYDROXYCHLOROQUINE SULPHATE IP 200 MG COLOUR: TITANIUM DIOXIDE IP	IP
624	NIFEDIPINE SUSTAINED RELEASE TABLETS IP 30 MG	EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS NIFEDIPINE IP 30 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW	IP
625	NIFEDIPINE SUSTAINED RELEASE TABLET IP 10 MG	EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS: NIFEDIPINE IP 10 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF	IP	DEC.1984
626	NIFEDIPINE SUSTAINED RELEASE TABLET IP 60 MG	EACH SUSTAINED RELEASE FILM COATED TABLET CONTAINS: NIFEDIPINE IP 60 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF	IP
627	SILVER NITRATE GEL 0.2% W/W	COMPOSITION: SILVER NITRATE IP 0.2% W/W ETHYL ALCOHOL IP 4% V/V GEL BASE Q.S.
628	NANOCRYSTALLINE SILVER GEL	COMPOSITION: EACH GRAM OF GEL CONTAINS: SILVER AS NANO PARTICLES 0.002 % PERFUMED GEL BASE Q.S. COLOUR: CARMOISINE		04.01.2008
629	SILDENAFIL CITRATE AND DAPOXETINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS: SILDENAFIL CITRATE IP EQ. TO SILDENAFIL 50 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR: BRILLIANT BLUE LAKE, QUINOLINE YELLOW LAKE, IRON OXIDE BLACK & TITANIUM DIOXIDE
630	TADALAFIL AND DAPOXETINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS: TADALAFIL IP 10 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
631	OMEPRAZOLE MAGNESIUM & DOMPERIDONE TABLETS	EACH ENTERIC COATED TABLET CONTAINS: OMEPRAZOLE MAGNESIUM IP EQ TO OMEPRAZOLE 20 MG DOMPERIDONE IP 10 MG EXCIPIENTS Q.S. APPROVED COLOUR USED
632	GLIBENCLAMIDE & METFORMIN HYDROCHLORIDE (SR) TABLETS IP	EACH UNCOATED BILAYERED TABLETS CONTAINS: GLIBENCLAMIDE IP 2.5 MG METFORMIN HYDROCHLORIDE IP 400 MG EXCIPIENTS Q.S COLOUR : RED OXIDE OF IRON	IP	26.11.1996
633	ATORVASTATIN, CLOPIDOGREL AND ASPIRIN CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS: ATORVASTATIN CALCIUM IP (AS PELLETS) EQ. TO ATORVASTATIN 20 MG CLOPIDOGREL BISULPHATE IP (AS PELLETS) EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (AS GASTRO-RESISTANT PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL.
634	PARACETAMOL EXTENDED RELEASE TABLETS 650 MG	EACH UNCOATED BILAYERED TABLET CONTAINS: PARACETAMOL IP 325 MG (AS IMMEDIATE RELEASE) PARACETAMOL IP 325 MG (AS EXTENDED RELEASE) APPROVED COLOUR USED		1996
635	SILODOSIN 8 MG TABLETS	EACH FILM COATED TABLET CONTAINS: SILODOSIN 8 MG EXCIPIENTS Q.S. COLOUR: LAKE SUNSET YELLOW FCF
636	LEVOCETIRIZINE DIHYDROCHLORIDE DISPERSIBLE TABLETS	EACH UNCOATED DISPERSIBLE TABLET CONTAINS: LEVOCETIRIZINE HYDROCHLORIDE IP 5 MG EXCIPIENTS Q.S.		27.07.2007
637	METHYLPREDNISOLONE TABLETS IP	EACH UNCOATED TABLET CONTAINS METHYLPREDNISOLONE IP 4 MG EXCIPIENTS Q.S.	IP
638	SAXAGLIPTIN TABLETS 5 MG	EACH FILM COATED TABLET CONTAINS SAXAGLIPTIN HYDROCHLORIDE EQ. TO SAXAGLIPTIN 5 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON & TITANIUM DIOXIDE IP
639	SAXAGLIPTIN TABLETS 2.5 MG	EACH FILM COATED TABLET CONTAINS SAXAGLIPTIN HYDROCHLORIDE EQ. TO SAXAGLIPTIN 2.5 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON & TITANIUM DIOXIDE IP
640	TAPENTADOL HYDROCHLORIDE TABLETS	EACH FILM COATED TABLETS CONTAINS TAPENTADOL HYDROCHLORIDE EQ. TO TAPENTADOL 100 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW FCF
641	ACECLOFENAC, LINSEED OIL,MENTHOL , METHYL SALICYLATE & CAPSAICIN GEL	COMPOSITION ACECLOFENAC BP 1.5% W/W LINSEED OIL (OLEUM LINI) BP 3.00% W/W MENTHOL BP 5.00% W/W METHYL SALICYLATE BP 10.00% W/W CAPSAICIN USP 0.025%W/W BENZYL ALCOHOL BP 0.1 % W/W GEL BASE
642	AMITRIPTYLINE HYDROCHLORIDE AND CHLORDIAZEPOXIDE TABLETS	EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 12.5 MG CHLORDIAZEPOXIDE IP 5 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
643	TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 47.5 MG EQ. TO METOPROLOL TARTRATE 50 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON
644	TELMISARTAN AND METOPROLOL SUCCINATE PROLONGED-RELEASE TABLETS	EACH UNCOATED BILAYERED TABLET CONTAINS TELMISARTAN IP 40 MG METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG (AS PROLONGED-RELEASE) EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON
645	AMITRIPTYLINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS AMITRIPTYLINE HYDROCHLORIDE IP EQ TO AMITRIPTYLINE 75 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
646	ESOMEPRAZOLE TABLETS (WITH SODIUM BICARBONATE AS BUFFER)	EACH FILM COATED TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ. TO ESOMEPRAZOLE 40 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP		14.05.2008
647	PANTOPRAZOLE & DOMPERIDONE MALEATE TABLETS	EACH ENTERIC COATED TABLET CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 30 MG EXCIPIENTS Q.S. COLOUR: YELLOW OXIDE OF IRON
648	PANTOPRAZOLE & DOMPERIDONE CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED) PELLETS DOMPERIDONE MALEATE IP EQ. TO DOMPERIDONE 30 MG (10 MG IMMEDIATE RELEASE AND 20 MG AS SUSTAINED RELEASE) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS
649	RAMIPRIL TABLETS IP 10 MG	EACH UNCOATED TABLET CONTAINS: RAMIPRIL IP 10 MG EXCIPIENTS Q.S.	IP	2005
650	CARVEDILOL PHOSPHATE EXTENDED RELEASE TABLETS	EACH UNCOATED EXTENDED RELEASE TABLETS CONTAINS: CARVEDILOL PHOSPHATE 10 MG EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP		11.12.2009
651	CARVEDILOL PHOSPHATE EXTENDED RELEASE TABLETS	EACH UNCOATED EXTENDED RELEASE TABLETS CONTAINS: CARVEDILOL PHOSPHATE 20 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW LAKE		11.12.2009
652	AMISULPRIDE TABLETS IP 400 MG	EACH FILM COATED TABLET CONTAINS: AMISULPRIDE IP 400 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW LAKE	IP	12.03.10
653	DICLOFENAC SODIUM TABLETS IP	EACH ENTERIC COATED TABLET CONTAINS: DICLOFENAC SODIUM IP 50 MG EXCIEPINTS Q.S. COLOUR: SUNSET YELLOW	IP
654	CHLORTHALIDONE 6.25 MG & METOPROLOL SUCCINATE EXTENDED RELEASE 25 MG TABLETS	EACH FILM COATED BILAYERED TABLETS CONTAINS CHLORTHALIDONE IP 6.25 MG METOPROLOL SUCCINATE IP 23.75 MG EQ. TO METOPROLOL TARTRATE 25 MG (AS EXTENDED RELEASE PART) COLOUR: INDIGO CARMINE & QUINOLINE YELLOW WS
655	NIFEDIPINE EXTENDED RELEASE TABLETS USP 60 MG	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS NIFEDIPINE USP 60 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE YELLOW USP & TITANIUM DIOXIDE BP	USP
656	TADALAFIL AND DAPOXETINE HYDROCHLORIDE TABLETS	EACH FILM COATED TABLET CONTAINS: TADALAFIL IP 20 MG DAPOXETINE HYDROCHLORIDE IP EQ. TO DAPOXETINE 30 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW
657	RAMIPRIL AND AMLODIPINE TABLETS	EACH UNCOATED TABLET CONTAINS RAMIPRIL IP 2.5 MG AMLODIPINE BESYLATE IP EQUIVALENT TO AMLODIPINE 5 MG EXCIPIENTS Q.S. COLOUR:TITANIUM DIOXIDE BP		04.10.2004
658	RAMIPRIL & HYDROCHLOROTHIAZIDE TABLETS	EACH UNCOATED TABLET CONTAINS RAMIPRIL IP 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. APPROVED COLOUR USE
659	MODAFINIL TABLETS IP	EACH UNCOATED TABLET CONTAINS MODAFINIL IP 100 MG EXCIPIENTS Q.S.	IP	16.12.2003
660	TORSEMIDE TABLETS IP 40 MG	EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 40 MG EXCIPIENTS Q.S.	IP
661	TORSEMIDE TABLETS IP 100 MG	EACH UNCOATED TABLET CONTAINS TORSEMIDE IP 100 MG EXCIPIENTS Q.S.	IP
662	CINITAPRIDE TABLETS 1 MG	EACH UNCOATED TABLET CONTAINS CINITAPRIDE HYDROGEN TARTRATE EQUIVALENT TO CINITAPRIDE 1 MG EXCIPIENTS Q.S.		1/4/2008
663	OLMESARTAN MEDOXOMIL AND CHLORTHALIDONE TABLETS	EACH FILM COATED BILAYERED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 40 MG CHLORTHALIDONE IP 6.25 MG EXCIPIENTS Q.S. COLOUR:SUNSET YELLOW
664	OLMESARTAN AND CHLORTHALIDONE TABLETS	EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG OLMESARTAN MEDOXOMIL IP 40 MG EXCIPIENTS Q.S. COLOUR:PONCEAU 4R
665	OLMESARTAN AND CHLORTHALIDONE TABLETS	EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 12.5 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW
666	CHLORTHALIDONE AND OLMESARTAN MEDOXOMIL TABLETS	EACH FILM COATED TABLET CONTAINS CHLORTHALIDONE IP 6.25 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USE
667	CILNIDIPINE AND OLMESARTAN MEDOXOMIL TABLETS	EACH FILM COATED TABLET CONTAINS CILNIDIPINE IP 10 MG OLMESARTAN MEDOXOMIL IP 20 MG EXCIPIENTS Q.S. APPROVED COLOUR USE
668	CARBIMAZOLE TABLETS IP	EACH UNCOATED TABLET CONTAINS CARBIMAZOLE IP 5 MG EXCIPIENTS Q.S. APPROVED COLOUR USE	IP
669	PARACETAMOL IMMEDIATE RELEASE 300 MG & SUSTAINED RELEASE 700 MG	EACH UNCOATED BIAYERED TABLET PARACETAMOL IP 300 MG (AS IMMEDIATE RELEASE) PARACETAMOL IP 700 MG (AS SUSTAINED RELEASE) EXCIPIENTS Q.S. APPROVED COLOUR USE
670	MINOXIDIL TOPICAL SOLUTION USP 10% W/V	COMPOSITION MINOXIDIL IP 10.0%W/V ABSOLUTE ALCOHOL CONTENT 40.0%V/V	USP
671	FLUOXETINE HCL CAPSULES IP 60 MG	EACH HARD GELATINE CPASULES CONTAINS FLUOXETINE HYDROCHLORIDE IP EQUIVALENT TO FLUOXETINE 60 MG	IP	1990-MARCH
672	BECLOMETHASONE DIPROPIONATE, PHENYLEPHRINE HYDROCHLORIDE & LIDOCAINE HYDROCHLORIDE CREAM	COMPOSITION: BECLOMETHASONE DIPROPIONATE IP 0.025 % W/W PHENYLEPHRINE HYDROCHLORIDE IP 0.10W/W LIDOCAINE HYDROCHLORIDE IP 2.50%W/W CREAM BASE Q.S.
673	RIVAROXABAN TABLETS 20 MG	EACH FILM COATED TABLET CONTAINS RIVAROXABAN 20 MG EXCIPIENTS Q.S. COLOUR:IRON OXIDE RED & TITANIUM DIOXIDE		02.09.14
674	RANOLAZINE EXTENDED RELEASE TABLETS 1000 MG	EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS RANOLAZINE 1000 MG EXCIPIENTS Q.S. COLOUR:IRON OXIDE RED		31.01.09
675	EPLERENONE TABLETS	EACH FILM COATED TABLET CONTAINS EPLERENONE IP 50 MG EXCIPIENTS Q.S. APPROVED COLOUR USE
676	NICOUMALONE TABLETS IP	EACH UNCOATED TABLET CONTAINS NICOUMALONE IP 2 MG EXCIPIENTS Q.S.	IP
677	NICOUMALONE TABLETS IP	EACH UNCOATED TABLET CONTAINS NICOUMALONE IP 3 MG EXCIPIENTS Q.S. COLOUR:QUINOLINE YELLOW	IP
678	RANITIDINE HYDROCHLORIDE TABLETS IP	EACH FILM COATED TABLET CONTAINS RANITIDINE HYDROCHLORIDE IP EQUIVALENT TO RANITIDINE 300 MG EXCIPIENTS Q.S. COLOUR:SUNSET YELLOW FCF & TITANIUM DIOXIDE IP	IP
679	BRIVARACETAM TABLETS 100 MG	EACH FILM COATED TABLET CONTAINS BRIVARACETAM 100 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP
680	FAROPENEM TABLETS JP 200 MG	EACH FILM COATED TABLET CONTAINS FAROPENEM SODIUM HYDRATE IP EQUIVALENT TO FAROPENEM 200 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF RED FERRIC OXIDE USP NF YEW & TITANIUM DIOXIDE IP	JP	16.04.08
681	GLIMEPRIDE, VOGLIBOSE & METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS	EACH FILM COATED BILAYERED SUSTAINED RELEASE TABLETS GLIMEPRIDE IP 2 MG VOGLIBOSE IP 0.2 MG METFORMIN HYDROCHLORIDE IP 500 MG (IN SUSTAINED RELEASE FORM) EXCIPIENTS Q.S. COLOUR :TITANIUM DIOXIDE & ERYTHROSINE
682	ACEBROPHYLLINE 100 MG + N-ACETYLCYSTEINE 600 MG TABLETS	EACH FILM COATED BILAYERED TABLET CONTAINS ACEBROPHYLLINE 100 MG N-ACETYLCYSTEINE BP 600 MG EXCIPIENTS Q.S. COLOUR : QUINOLINE YELLOW
683	OLMESARTAN, AMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS	EACH FILM COATED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 20 MG AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP
684	OLMESARTAN, AMLODIPINE & HYDROCHLOROTHIAZIDE TABLETS	EACH FILM COATED TABLET CONTAINS OLMESARTAN MEDOXOMIL IP 40 MG AMLODIPINE BESYLATE IP EQ.TO AMLODIPINE 5 MG HYDROCHLOROTHIAZIDE IP 12.5 MG EXCIPIENTS Q.S. COLOUR :SUNSET YELLOW
685	SILDENAFIL CITRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS SILDENAFIL CITRATE IP EQ.TO SILDENAFIL 25 MG EXCIPIENTS Q.S. COLOUR : RED OXIDE OF IRON	IP	08.01.2001
686	ZOLPIDEM TARTRATE TABLETS IP	EACH FILM COATED TABLET CONTAINS ZOLPIDEM TARTRATE IP 10 MG EXCIPIENTS Q.S. COLOUR : TITANIUM DIOXIDE IP	IP	12.10.15
687	ACECLOFENAC AND PARACETAMOL SUSPENSION	EACH 5 ML CONTAINS ACECLOFENAC IP 50 MG PARACETAMOL IP 125 MG FLAVOURED SYRUP BASE Q.S. COLOUR: SUNSET YELLOW
688	TAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE TABLETS 0.4 MG	EACH FILM COATED TABLET CONTAINS TAMSULOSIN HYDROCHLORIDE IP 0.4 MG (AS MODIFIED RELEASE) EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP
689	PREGABALIN SUSTAINED RELEASE & METHYLCOBALAMIN TABLETS	EACH UNCOATED TABLETS CONTAINS PREGABALIN IP 75 MG (IN SUSTAINED RELEASE FORM) METHYLCOBALAMIN IP 750 MCG EXCIPIENTS Q.S. COLOUR: PONCEAU 4R LAKE
690	DOXYLAMINE SUCCINATE 20 MG, PYRIDOXINE HYDROCHLORIDE 20 MG & FOLIC ACID 5 MG TABLETS	EACH ENTERIC COATED TABLET CONTAINS DOXYLAMINE SUCCINATE BP 20 MG PYRIDOXINE HYDROCHLORIDE IP 20 MG FOLIC ACID IP 5 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE
691	ALBENDAZOLE SUSPENSION IP	EACH 10 ML CONTAINS ALBENDAZOLE IP 400 MG FLAVOURED SYRUPY BASE Q.S. APPROVED COLOUR USED	IP
692	SILODOSIN CAPSULES	EACH HARD GELATIN CAPSULE CONTAINS SILODOSIN 8 MG EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL.
693	PANTOPRAZOLE GASTRO-RESISTANT AND DOMPERIDONE PROLONGED-RELEASE CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS PANTOPRAZOLE SODIUM SESQUIHYDRATE IP EQ. TO PANTOPRAZOLE 40 MG (AS ENTERIC COATED PELLETS) DOMPERIDONE IP 30 MG (AS SUSTAINED-RELEASE PELLETS) EXCIPIENTS Q.S. APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL AND PELLETS	IP
694	ASPIRIN GASTRO-RESISTANT AND ROSUVASTATIN CALCIUM CAPSULES IP	EACH HARD GELATIN CAPSULE CONTAINS: ROSUVASTATIN CALCIUM IP EQ. TO ROSUVASTATIN 10 MG ASPIRIN IP 75 MG (AS ENTERIC COATED) APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS	IP	30.03.11
695	NICORANDIL TABLETS IP	EACH UNCOATED TABLET CONTAINS NICORANDIL IP 10 MG EXCIPIENTS Q.S.	IP	10.01.1997
696	NICORANDIL TABLETS IP	EACH UNCOATED TABLET CONTAINS NICORANDIL IP 5 MG EXCIPIENTS Q.S	IP	10.01.1997
697	CLOPIDOGREL AND ASPIRIN TABLETS IP	EACH FILM COATED BILAYERED TABLET CONTAINS CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 75 MG (IN COATED FORM) EXCIPIENTS Q.S. COLOUR: LAKE OF SUNSET YELLOW	IP
698	CLOPIDOGREL AND ASPIRIN TABLETS IP	EACH FILM COATED BILAYERED TABLET CONTAINS CLOPIDOGREL BISULPHATE IP EQ. TO CLOPIDOGREL 75 MG ASPIRIN IP 150 MG (IN COATED FORM) EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON	IP
699	BACLOFEN TABLETS IP	EACH UNCOATED TABLET CONTAINS BACLOFEN IP 10 MG EXCIPIENTS Q.S.	IP
700	BACLOFEN TABLETS IP	EACH UNCOATED TABLET CONTAINS BACLOFEN IP 20 MG EXCIPIENTS Q.S.	IP
701	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (SUSTAINED-RELEASE) TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE EQ. TO DAPAGLIFLOZIN 10 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED-RELEASE FORM) EXCIPIENTS Q.S.
702	ARTEMETHER & LUMEFENTRINE FOR ORAL SUSPENSION	EACH 5 ML (AFTER RECONSTITUTION) CONTAINS ARTEMETHER IP 20 MG LUMEFANTRINE USP 120 MG EXCIPIENTS Q.S. COLOUR: SUNSET YELLOW
703	ARTEMETHER & LUMEFENTRINE FOR ORAL SUSPENSION	EACH 5 ML (AFTER RECONSTITUTION) CONTAINS ARTEMETHER IP 40 MG LUMEFANTRINE USP 240 MG EXCIPIENTS Q.S. COLOUR: TARTRAZINE YELLOW SUPRA		05.10.2011
704	BISOPROLOL FUMARATE TABLETS USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE USP 5 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF (RED) & TITANIUM DIOXIDE IP	USP	27.02.1992	19.10.2024
705	BISOPROLOL FUMARATE TABLET USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 2.5 MG EXCIPIENTS Q.S. COLOUR: PONCEAU 4R LAKE & TITANIUM DIOXIDE IP	USP	19.01.2001	19.10.2024
706	BISOPROLOL FUMARATE TABLET USP	EACH FILM COATED TABLET CONTAINS BISOPROLOL FUMARATE IP 10 MG EXCIPIENTS Q.S. COLOUR: FERRIC OXIDE USP NF (YELLOW), FERRIC OXIDE USP NF (RED) & TITANIUM DIOXIDE IP	USP	27.02.1992	19.10.2024
707	SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET	EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: IRON OXIDE RED, IRON OXIDE BLACK & TITANIUM DIOXIDE IP		28.04.2008	19.10.2024
708	SITAGLIPTIN PHOSPHATE AND METFORMIN HYDROCHLORIDE TABLET	EACH FILM COATED TABLET CONTAINS SITAGLIPTIN PHOSPHATE MONOHYDRATE IP 64.25MG EQ. TO SITAGLIPTIN 50 MG METFORMIN HYDROCHLORIDE IP 1000 MG EXCIPIENTS Q.S. COLOUR: IRON OXIDE RED, IRON OXIDE BLACK & TITANIUM DIOXIDE IP		28.04.2008	19.10.2024
709	AMLODIPINE TABLETS IP	EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 2.5 MG EXCIPIENTS Q.S.	IP	20.05.2009	19.10.2024
710	AMLODIPINE & ATENOLOL TABLETS IP	EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG ATENOLOL IP 50 MG EXCIPIENTS Q.S. COLOUR: LAKE OF SUNSET YELLOW FCF	IP	20.05.1996	19.10.2024
711	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (SUSTAINED-RELEASE) TABLETS	EACH UNCOATED BILAYER TABLET CONTAINS DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE EQ. TO DAPAGLIFLOZIN 10 MG METFORMIN HYDROCHLORIDE IP 1000 MG (IN SUSTAINED-RELEASE FORM) EXCIPIENTS Q.S. COLOUR: TITANIUM DIOXIDE IP			19.10.2024
712	GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 1 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: RED OXIDE OF IRON			19.10.2024
713	GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE TABLETS	EACH UNCOATED TABLET CONTAINS: GLIMEPIRIDE IP 2 MG METFORMIN HYDROCHLORIDE IP 500 MG EXCIPIENTS Q.S. COLOUR: QUINOLINE YELLOW			19.10.2024
714	AMLODIPINE TABLETS IP	EACH UNCOATED TABLET CONTAINS AMLODIPINE BESYLATE IP EQ. TO AMLODIPINE 5 MG EXCIPIENTS Q.S.	IP	20.05.2009	19.10.2024

Rated 4 out of 5

From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.

Anil Dubay

Rated 4 out of 5

Lorem ipsum dolor sit amet, quia non consectetur adipiscing elit

Rajarshi Sarkar August 16, 2020

Rated 4 out of 5

Excellent support and communication on completing the project and shown great degree of flexibility with changing timelines, guidance to team for implementation of solution.

Rakesh Malhotra

Rated 4 out of 5

From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.

Anil Dubay

Rated 4 out of 5

Lorem ipsum dolor sit amet, quia non consectetur adipiscing elit

Rajarshi Sarkar August 16, 2020

Rated 4 out of 5

Excellent support and communication on completing the project and shown great degree of flexibility with changing timelines, guidance to team for implementation of solution.

Rakesh Malhotra

Rated 4 out of 5

From my first contact with Xenobiotics I have found them to be a very impressive company. The expert knowledge, exceptional customer service, and attention to detail have been a refreshing change when compared to other companies in the industry. The ability to outsource select products to them has allowed us to meet our operational challenges. In all this Xenobiotics has been very flexible and supportive.

Anil Dubay

prev

next

We Are Available. Interested in Collaboration?

Get in Touch